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ABSTRACT 
The protein requirement of synapses poses a unique problem 
as they are located at some distance from the cell body. The 
macromolecular requirement of synapses is a problem by itself 
in normal state, as well as in pathological conditions. The 
question arises as to whether synapses synthesize all their 
proteins or do they depend on the cell body for proteins. 
As a model to study such a mechanism, we chose a system of 
isolated synaptosomes and microsomes from 20 and 58 .day :.:at 
brain previously injected with DFP and studied specifically 
the synthesis of ACbE. In 20 day old rats, following DFP, 
47% of the inhibited AChE was synthesized at nerve endings, 
while for the same period 112% of the inhibited enzyme was 
synthesized at microsomes. Since this period represents a 
period of rapid growth in the animal, attempts were made to 
differentiate the enzyme arising due to nom.al growth and 
those arising due to enzyme replacement after DFP inhibition. 
After the appropriate corrections, it was found that AChE 
synthesized to replace the DFP inhibited enzyme a.mounted to 
43% at the nerve endings and to 16% at the microsomes. In 
58 day old rats, 64% of the inhibited nerve ending AChE was 
synthesized and for the same period microsomes synthesized 
45% of the inhibited enzyme. This phenomenon was not an age 
dependent one as it was found in both age groups. ACbE was 
found to be synthesized at nerve endings without a concomittant 
increase or decrease of microsomal enzyme which suggested an 
independent synthesizing machinery of nerve endings. When 
Triton X-100 was used to solubilize AChE, the inhibition due 
to DFP was considerably less in nerve terminals and microsomes 
compared to DFP inhibition measured in buffer treated fractions. 
These results suggest that a reservoir of the enzyme is not 
available to substrate and to inhibitors such as DFP. 
We also found differences in the rate of inhibition and 
recovery of isoenzymes in the rrlicrosomal and nerve ending 
fraction following DFP which further confirmed the independent 
synthesizing machinery of the nerve endings. On the day of 
injection:, the order of inhibition of the 4 microsomal iso-
enzymes was 81, 49, 25 and 03 for isoenzymes 4,3,2,1. Fifteen 
days following DFP, the inhibition of isoenzyme 4 was 363 and 
isoenzyme 2 was 253. In the same period, inhibited isoenzyme 
3 was completely replaced by newly :. synthesized AChE. The in-
hibition and recovery of nerve ending isoenzyme were also studied 
in a manner similar to those of the rrlicrosomal isoenzymes. On 
the day of injection, the isoenzymes 4,3,2 and 1 were inhibited 
83, 30, 4 and 82% respectively. Fifteen days following DFP 
injection, the inhibition of isoenzyme 4 and 1 was 16 and 25 
percent respectively. Inhibited isoenzyme 3 and 2 were com-
pletely replaced by newly synthesized enzyme. The isoenzymes 
of nerve ending demonstrated different order of sensitivity to 
DFP and of the recovery rate indicating a different turnover rate. 
Certain hypothesis were made regarding the function of 
these isoenzymes. Microsomes might supply the enzyme around 
the cell body which prevents the proliferation of Ach into 
cell from other sources. Nerve endings might supply the 
enzyme at the junctional complex whose main role is to hydro-
lyze the transmitter following · chemical transmission. 
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INTRODUCTION 
BACKGROUND 
The studies of the ultrastructure of the CNS demonstrated 
that the central nervous system is a highly organized assembly 
of cells as originally postulated by His (1886), and not a 
continuous syncytium as originally suggested by the reticu-
larists (Golgi, 1907). Two types of cells are found: the 
neurons or nerve cells and the neuroglia or supporting cells. 
Although both types of cells maintain the architecture of 
nervous system, the transmission and integration of information 
relayed by the nerve impulses are the unique function of neurons, 
STRUCTURE OF THE NEURON AND OF SYNAPSES 
The neuron is a complete anatomical unit composed of a 
nucleus, cytoplasm and a surrounding membrane which protects 
the cell constituents and forms a boundary with respect to 
other elements in the nervous tissue. Varieties of neurons 
may be differentiated on the basis of the differences in 
size, shape, distribution and on the number and spread of 
their processes. The typical neuron has a soma, a series of 
processes called dendrites, and an axon. Dendrites originate 
at the soma and distribute in all directions; the axons stem 
from the soma or from a large dendrite and terminate at vary-
ing distances in contact with other nerve cells, muscle 
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fibers or with gland cells. 
In the vertebrates, neurons can be monopolar, bipolar 
or multipolar, depending upon the pattern and characteristics 
of their processes. Most neurons have a large number of den-
drites emerging from cell body and for this reason are said 
to be multipolar. When a single process arises from cell 
body, the neuron in question is monopolar; when two processes 
arise from cell body, the pertinent neurons are bipolar. In 
mammals the diameter of the neuronal soma varies from few 
microns, as in the case of granular cells in cerebellar 
cortex, to close to a tenth of a millimeter for the large 
vestibular cells of the medulla oblongata and the motor 
neurons in the anterior horn of the spinal cord. 
Dendrites are extensions of the perikaryon of a 
neuron. They contain the same organelles as the perikaryon 
and are never ensheathed by myelin. Axons on the other 
hand may or may not be ensheathed bymyelin. Microtubules 
are the most prominent elements in the cytoplasm of large 
dendrites arising from multipolar cells, Other cytoplasmic 
organelles are neurofilaments, endoplasmic reticulum, mi to--
chondria, golgi apparatus, vesicles and multivesicular 
bodies, A granular endoplasmic reticulum shows .distribu--
3 
tion similar to that of perikaryon. In axon, few ribosomes 
are present in the initial segment, but they do not extend 
beyond it. The remainder of the axon .is devoid of ribosomes, 
but it contains mitochondria, neurofilaments and multivesicu--
lar bodies; it is characterised by absence of two components 
that are present elsewhere, granular endoplasm5c reticulum 
and free ribosomes. 
The morphology of the neuronal tontacts is consistent 
with Ramon y Cajal's neuron theory; this theory states in 
effect that the transmission of nerve impulses from one 
cell to another is mediated through functional contacts 
specialized for transmission, which were defined originally 
by Sherrington (1897) as synapses, Electron microscopy and 
SQbcellular neurochemistry has enormously advanced our 
knowledge of synapses in the central nervous system; the 
pertinent studies were particularly advanced by three 
modern investigators and their associates: De Robertis 
(1958, 1959), Palay (1958) and Whittaker (with Gray, 1962), 
As can also be seen in our ovm microphotographs (cf. Results), 
the presynaptic fiber ends in an expanded terminal, the 
synaptic knob which is intimately associated with a portion 
of the membrane of th~ postsynaptic neuron, The subsynaptic 
membrane is separated from the synaptic knob by a.very 
narrow and remarkably uniform space, the synaptic cleft. 
p 
4 
The synaptic knob contains several mitochondria and, most 
characteristically, large number of.synaptic vesicles, 300 
• to 6oO A in diameter. Synaptic vesicles were independently 
recognized by two early investigators who employed electron~ 
microscopy (De Robertis and Bennett 1954, 1955; Palade and 
Palay, 1954); the synaptic vesicles are of particular signi-
ficance because there is much evidence that they contain 
preformed packets of the transmitter. 
FUNCTION OF THE NEURON 
In the brain, transmission across relatively signi-
ficant distances is carried by axons; this t:ype of trans-
mission may be referred as conduction or propagation of 
nerve impulses which occurs in an all or none fashion .. 
The axons are specialized for conducting information from 
one place to another. The impulse discharged travels 
along the various branches (10 to hundreds) of an axon, 
to activate synapses thereon. According to the principle 
of convergence, neurons receive synapses from many neurons; 
these synapses can be excitatory or inhibitory. The synapses 
are the locus of the so-called synaptic transmission. The 
number of synapses at a neuron vary, the highest recorded 
being 80,000. A neuron receives information through sy-
napses located on its dendrites and soma, integrates this 
information and propagates it over its axon to other nerve 
pt 
cells. 
We turn now to the question of how nerve impulses 
spread dovm the axon. The key to the mechanism of' this 
impulse propagation are the all-or··none principle of pro-
pagation, as well as the phenomenon of passive spread. At 
any point in the axon, the action potential spreads to the 
neighboring regions where the depolarization acts as a 
stimulus to produce another action potential and so on 
duvm the axon. The all-or-none method of propagation 
assures that the action potential will always be full'" 
sized, thereby minimizing the chances that it will get 
lost along the way. In unmyelinated nerve and in muscle, 
the spread of current is continuous and conduction appears 
to be a uniform process. The propagated action potential 
is further accelerated by glial myelin sheaths causing 
the action potential in myelinated axon to leap from node 
to node. The conduction is discontinuous or saltatory 
5 
and the impulse skips from one node to node in myelinated 
nerve fibers as proposed originally by Lillie (1925). The 
active generation of current(generation of action potential) 
is confined to the nodes of Ranvier. The myelin acts as an 
insulator with a low electrical capacity which increases 
conduction velocity by making the local circuit act at a 
considerable distance ahead of the active region. Applying 
p 
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the sodium permeability theory to saltatory conduction, it 
can be said that sodium ions enter myelinated axons at the 
nodes but depolarize the whole fiber by local circuit action. 
No one has yet been able to test this particular point directly 
but there is now a large body of indirect evidence in favor 
of saltatory theory (Tasaki, 1939, l955). 
When the nerve impulses reach the axon's synaptic ter-
minations on a dendrite, axon or soma)nerve impulse frequency 
appears to be transduced into a postsynaptic depolarization 
or hyperpolarisation similar in magnitude electrically to 
the one which originally generated the axon nerve impulse. 
It has been shown that the arriving nerve impulse causes the 
release of a small quantity of a chemical from presynaptic 
terminal generically known as a transmitter substance which 
diffuses across the synaptic cleft and results in the den-
dritic electrical response (depolarisation or hyperpolarisa-
tion). Unlike the axonal membrane, the dendritic membrane 
is said to be only chemically excitable. Ions may depolarise 
a dendritic membrane, but the release has to be induced by a 
chemical transmitter. 
SYNAPTIC TRANSMISSION 
There is sufficient evidence to indicate that the 
chemical transmitter acetylcholine (Ach) is released in uni-
form packets at nerve muscle junction (quanta) consisting of 
a relatively large number of molecules (Hubbard, 1970). The 
pa 
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quantal nature of transmission is currently thought to be con-
sequence of the storage of Ach in synaptic vesicles found in 
motor nerve terminal, ganglia and central neurons, the contents 
of each vesicle forming a quantum. 
Quantal release is thus equivalent to release of the 
contents of a synaptic vesicle into a synaptic cleft. Results 
accumulated indicate that basically the same process is pre-
sent at many peripheral and central synapses where variou.:, 
chemical mediators, including Ach, are involved in the trans--
mission of impulses. 
The transmitter substance parcelled inside a vesicular 
bag is separated from the postsynaptic target by two barriers, 
the vesicular membrane itself and the membrane of axon ter 
mi~al. Release probably occurs upon the collision between 
vesicular and axonal membranes. As proposed by Katz (1966), 
the release of transmitter occurs by exocytosis (collision 
between vesicle and axonal membranes). Ultrastructural evi-
dence to support this hypothesis was obtained in several 
instances as in the case of secretion of zymogen granules 
(Palade, 1959) and in that of neurosecretory activity 
(Smith and Smith, 1966). There are suggestions that this 
process is rapidly reve~sible so that a vesicle having 
discharged its contents would quickly detach itself from 
pas 
the membrane and start reaccumulating the transmitter sub-
stance. Similar processes occur for various transmitters 
centrally and peripherally. 
After the transmitter is released from its storage 
site by presynaptic action potential, it impinges upon the 
postsynaptic side and combines with specific macromolecules 
(the receptors). 
The receptors control channels in the subsynaptic mem-
brane for the passage of Na+, K+ and Cl-. By altering the 
conformation of the receptor protein, the transmitter in-
duce the postsynaptic potential (PSP). The postsynaptic 
potential could either depolarize or hyperpolarize the cell· 
Since depolarization of the neuron results in the production 
of nerve impulses, the depolarizing postsynaptic potential 
8 
is termed excitatory postsynaptic potential (EPSP). The 
hyperpolarizing postsynaptic potential is termed inhibitory 
postsynaptic potential (IPSP). IPS~ opposes the action of 
EPSP's and tends to prevent the generation of action poten-
tial, The generation of EPSP or IPSP depends upon the nature 
of postsynaptic cell receptor and of the particular trans-
mitter agent involver.. They can occur in the same cell. 
P' 
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EPSP's and IPSP's arriving over different synapses 
upon the neuron are summated approximating simple algebraic 
addition. The effect of IPSP is subtracted from total EPSP's. 
This property is known as spatial summation. Thus, various 
inputs to a neuron combine by summation to determine the 
single output. As the dendrites are electrically unexcit-
able, there must be some region of the cell closest to the 
dendrites which is electrically excitable. This region is 
believed to be axon hillock, the junction between soma and 
axon. Thus, a depolarization arising in a dendrite spreads 
passively down the dendrite through the soma and finally to 
the axon hillock where nerve impulses can be generated. The 
postsynaptic cell integrates and summates these potential; 
when the threshold is reached it gives off in terms of the 
all-or-none principle action potential at the axon hillock 
which is then propagated to each of its own axon terminals 
providing for the continuation of the impulse. Summation 
of the impulse is carried out by the postsynaptic cell. 
NATURE AND LOCALIZATION OF THE PATHWAYS IN CENTRAL NERVOUS SYSTEM 
Due to difficulties involved in studying the various 
pathway in central nervous system, their nature and localiza-
tion have not yet been fully determined. Various approaches 
have been utilized. Macro- and micro-electrodes were employed 
p 
10 
to study the neuronal responses to pertinent drugs and putative 
neuro transmitters • It was also attempted to demonstrate the 
release of transmitter upon the stimulation of nerve tracts 
and neurons. In the case of the central nervous system, 
several criteria have to be met to establish a substance as a 
neuro transmitter. 
(a) The appropriate nerve soma or set of nerve axons is select-
ively stimulated and the release of the transmitter detected 
upon passage of action potentials. In the case of the brain 
it is however impossible today to detect and chemically analyze 
the release without destroying the functional and structural 
integrity of the region of the brain being analyzed. Further-
more, it is difficult or impossible to detect such a release 
upon the stimulation of a single neuron or of a homogeneous 
group of neurons. However, the release was studied in brain 
slices incubated in physiological buffer solutions in vivo. 
They contain, of course, heterogeneous neuronal populations. 
(b) Indirect evidence is derived from the study of the dis-
tribution of the putative transmitters and of the enzymes 
involved in the synthesis and in the breakdown of the trans-
mitter. 
(c) Furthermore the study of the pharmacology of r'·.:sponses 
to presynaptic stimulation as compared to that of the responses 
to applied putative neurotransmitter may yield indirect evidence 
for the role of the latter in synaptic transmission. 
p 
ROLE OF Ach AS. A TRANS.MITTER IN THE CENTRAL NERVOUS S~?..TEM 
In 1954,Eccles and his associates provided pharma-
cological evidence for the cholinergic nature of spinal 
synapses. Acetylcholine was shown to be the transmitter 
in the motor neuron collaterals to the Renshaw cell (Eccles 
et al., 1954, 1956). In the subsequent work of Eccles, 
Curtis and }\yall (1958) a multimicro electrode system with 
a multibarrel micropipette was employed for iontophoretic 
release of drugs and for unit fire recording. Ach, nicotine 
and cholinomimetic substance were effective in increasing 
the rate of or initiating discharge from the Renshaw cell. 
11 
Searching for cholinoceptive neurons in other central 
areas, Curtis and Koizumi (1961) and Bradley and Wolstencroft 
(1965), Curtis and Crawford (1969) studied medullary and 
mesencephalic reticular formation and the inferior colliculus. 
Cells responding to Ach were found only in the latter region. 
The response to Ach were not affected by dihydro f'-erythroidine, 
d-tubocurarine and physostigmine. Parenthetically, inferior 
c_olliculus contains moderate amount of ChAc and ChE. 
Further studies in which iontophoretic methods were 
employed demonstrated that the following sites are cholino-
ceptive: Caudate nucleus, ventral basal thalamus, lateral 
geniculate body, the supraoptic nucleus and postomedial parts 
of the thalamus, cochlear nucleus, brain stem, pyramidal cells 
l2 
of the cortex and certain cerebellar neurons {Curtis, 1966; 
Curtis and Anderson, 1962; Curtis and Davis, 1963 and Curtis 
and Eccles, 1958; Curtis and Crawford, 1969; and Krnjevic, 
1974). 
Furthermore, Krnjevic and Phillis (1963) suggested that 
Ach may act as a sensory transmitter at the thermal receptors. 
Similarly, taste fibre endings and chemoreceptors also seem to 
be Ach sensitive and excitable i~pon application of Ach. 
Two additional lines of evidence should be added. 
Synaptic vesicles were found in association with Ach and minia-
ture postsynaptic potentials in the mammalian and amphibian 
brain {Katz and Miledi, 1963; Brock et al., 1951). These 
miniature potentials were not analysed phannacologically and 
their presence, as well as that of vesicles, cannot as yet be 
considered as dire~t evidence of the cholinergic nature of per-
tinent central synapses {Eccles, 1964). 
Second, several investigators have shown that in the 
presence of anti-ChE's, Ach is continually released from the 
brain {Elliott et al., 1950; Macintosh and Oborin, 1953) and 
that administration of anti-ChE agents increases l'rain levels 
of Ach {Michaelis et al., 1957). 
13 
It should be stated that pharmacological data are con-
clusive only with regard to cholinergicity of the synapse at 
the Renshaw cell, and perhaps with certain synapses in the 
cortex, thalamus and in the cerebellum, and in the supra 
optic nuclei. It is possible that central cholinergic cells 
respond differentially to muscarinic and nicotinic substances. 
The muscarinic response may be modulatory and facilitatory 
in character, as proposed by Krnjevic (1969), this can be 
also argued on the basis of analogy between the central 
and ganglionic muscarinic responses (Karczmar, et al., 
1969). It should be added that Bradley and Wolstencroft (1965) 
described a fast, depressant responses of certain cortical 
and subcortical neurons. Again, this response may illus-
trate the modulatory rather than synaptic role of central 
Ach. While otherwise central cholinergic synapses may be 
scattered, they are presumably important in the reticular 
formation and limbic system or diff'use mesendiencephalic 
system. 
MEMBRANE EFFECTS OF Ach: 
Ach has been found to have various membrane effects 
other than the neuro transmitter activity. 
Ach stimulates the incorporation of inorganic phosphate 
into phospholipid (Hok.in, 1966). It has been shown that Ach 
p 
14 
at a concentration of l0-4M stimulates the incorporation of 
32p into phospholipid, especially phosphoinositol and phos-
phatidic acid, as demonstrated in the case of the salt gland, 
sympathetic ganglia, brain slices and brain homogenates. 
Current evidence suggests that Ach stimulates the .hydrolysis 
of phosphoinositides in synaptosomes to form membrane bound 
diglyceride; it is thought that diglyceride is rate limiting 
in the synthesis of both phosphatidic acid and phosphoinositide 
Ach seems to be involved in the liberation of bioactive 
substances. Itokawa and Cooper (1970) have shown that Ach 
will release thiamine from perfused nerve preparations; it 
has also been shown to release catecholamine from chromaffin . 
cells and possibly at other sites (Glisson and Karczmar, 1971; 
Burn, et aL, 1963). Thus, Ach may also participate in the 
central phenomenon by releasing active bioamines such as nore-
pinephrine (NE) or dopamine (DE). Ciliary movement in gill 
plates of Mytilus edulis and ciliary motility in respiratory 
and esophageal tracts in mammals are supposed to be controlled 
by Ach (cf. Karczmar, 1963). 
ROLE OF Ach IN BEHAVIOR: 
A short description of the role of Ach in behavior was 
included to show the importance of cholinergic system and to 
justify our work on AChE. An attempt has been made to corre-
late behavioral changes with the Ach content of the brain 
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(Stein, 1970; Karczmar, 1970). Ach level seems to be de-
creased during convulsions. There.was an increase in Ach 
content during sedation or anasthesia. Furthermore, it was 
hypothesized that the relation between the adrenergic and 
cholinergic system is significant in the control of behavior. 
Earlier investigators suggested that behaviorally, cholinergic 
a 
system is opposed to adrenergic system (Frommel et al., 1947', 
b 1947 , 1951; Aprison, 1969). Carlton (1963, 1964) advanced 
this hypothesis on a more sophjstica~ed level. He suggested 
that cholinergic system preferentially antagonizes adrenergic 
activation of unrewarded behavior and minimizes the impact of 
iTrelevant stimuli. Therefore, blockade of unrewarded behavior 
by the cholinergic system should lead to better learning. T4is 
is confirmed by data of some (Whitehouse, 1959) but not all 
investigators (Bignami and Rosie, 1971). 
Another generalization was proposed by Rosenzweig and 
his collaborators. They associated very small differences 
in AChE and Ach activity of rat cortex with "flexible" be-
havior. Rats kept in complex environment showed 2-6% more 
cerebral AChE activity and cortical weight than rats bred 
in isolation. 
Altogether, it has been suggested that cholinergic 
system is responsible for suppression of avoidance and of 
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non-rewarded operant behavior, for depressed overt behavior 
and sleep, and for flexible response to environmental changes; 
more specifically, it was shown that the cholinergic system 
is involved in a number of appetitive and emotional behavior 
including aggression and sexual function, temperature control, 
etc.' (for references, cf. Karca.."11.ar, l975). Finally, behavior 
pattern must involve most complex circuitry, in which the 
cholinergic system plays a limited if not a minor part (Eccles, 
1964a, l964b; Karczmar, et al., 1971). Thus, this system may 
have simple or key role and it is impossible to assign it to 
specific neurophysiological substrates of behaviors in question. 
ANA.BOLIS!.1. AND CATABOLISM OF ACETYLCHOLINE: SYNTHESIS: 
Acetylcholine is synthesized in a reaction catalyzed by 
choline acetyltransferase (choline acetylase): 
ATP+acetate -) Adenyl acetate+pyrophosphate 
Adenylacetate+Co.A. --7 Acetyl Co.A.+AMP 
Acetyl Co.A. + Choline-? Ach + Co.A. 
Choline acetylase 
Thus, the overall reaction is 
Acetate +ATP + Choline ~Ach +AMP + pyrophosphate 
From the exp~riments on the superior cervical ganglion 
both in Feldberg's and in Macintosh's laboratories and from 
the studies of Fitzgerald (1968), it appears that choline 
is rate limiting in the synthesis of acetylcholine. 
p 
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Pathways involved in the anabolism and catabolism of acetyl-
choline are as follows: 
Phosphatidyl ethanola.mine 
Sadenosyl I 
methionine 1 
Phosphatidyl 
choline 
Cytidine Diphosphate 
Choline/I\ 
Diglyceride 
-.t.-Fatty acid CTF 
Glycerophosphocholine glyceropho~ph~ 
Citrate Glucose Choline Phosphoryl 
~ rl / . Choline 
Acetyl ~~ » • 
CoA ~ Ach > Cholin 
Betaine 
J, 
Serine 
HYDROLYSIS: 
Enzymatic hydrolysis of Acetylcholine is performed 
by cholinesterases which hydrolyse acetylcholine into choline 
and acetic acid. 
E + Ach -.;i. E Ach 
E Ach --=r Acetyl E + Choline 
Acetyl E + ~O --?> E + Acetate 
It is universally agreed that cholinesterases form a family 
of enzymes, isozymes and variants; in fact, we cannot be 
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certain how many cholinesterases exist in the body and what 
are their specific roles. This subject will be discussed now. 
PROPERTIES OF CHOLINESTERASES: TYPE OF CHOLINESTERASES 
- -
Augustinsson (1963) defined cholinesterases as a group 
of esterases which hydrolyse cholinesters at higher rates 
than non-choline esters, when hydrolysis rates are compared 
at optimum conditions as regards substrate concentration, 
pH, ionic strength, etc. Two types of cholinesterases most 
frequently encountered in mammals are the serum enzyme de-
signated at various times as pseudo or non-specific S-type 
ChE and at present as cholinesterase (EC, 3.1.1.8) and the 
true, specific or C-type ChE, at present designated as 
acetylcholinesterase (AChE) (EC, 3.1.1.7). 
Other related esterases are kno~m. Ali- and aryl-
esterases do not hydrolyse choline esters while they are 
effective against alkyl and aryl esters respectively. These 
and other ChE's may be distinguished by their inhibitory char-
acteristics; as shown early by Mounter and Whittaker (1950). 
ChE's are inhibited by organophosphorus compounds and 
carbamates, aliesterases are inhibited by organophosphorus 
compounds but not by carbamates, while aryl ester?ses are 
inhibited by neither organophosphorus compounds nor carba-
mates. The organophosphorus anticholinesterases such as 
jP 
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diisopropyl phosphofluoridate (DFP) are generally more potent 
inhibitors of cholinesterases than of acetylcholinesterase, 
whereas oxamide derivatives (Ambenonium) are about two thousand 
times more potent as an inhibitor of acetylcholinesterase than 
of cholinesterase (Lands et al., 1955). 
In the further discussions, AchE will refer to true or 
specific cholinesterase, BuChE will refer to pseudo or cholin-
esterase. 
The two groups AchE and ChE may be differentiated generally 
not only by means of selective inhibitors, but also by means of 
specific substrates. AchE hydrolyses Ach most ra:e_i.<!lz, but the 
other choline esters ~ slow~z. AchE is inhibited by high 
substrate concentration; when the hydrolysis rate obtained 
with pure AchE is plotted against the logarithm of substrate 
concentration, bell shaped curves are obtained. The optimum 
substrate concentration for the AchE - Ach system is at about 
3xio-3M and the dissociation constant (Ks} for the AchE-Ach 
complex is about 5x10-~. All ChE's so far studied split 
butyryl choline at a higher rate than other esters of choline 
and give the usual dissociation curves (Ks-2xl0-3) with butyryl 
choline, propionychr.line and Ach. The esterase activity is not 
inhibited by high concentrations of these substrates. 
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ACETYLCHOLINESTERA.SE: 
Acetylcholinesterase is of particular importance because 
of its role in synaptic and neuroeffector transmission. AchE 
has been analyzed thoroughly at the molecular level by various 
workers, beginning with Nachmansohn and Wilson (1951). Acetyl-
cholinesterase has been crystallized from electric eel (Kremzner 
and Wilson, 1964). An electrophoretically homogeneous moiety 
·was found to have a molecular weight of 240,000 (Leuzinger and 
Baker, 1967). 
Nachmansohn and Wilson (1951) found the two main subsites 
at the active centre of AchE, one being the anionic site which 
attracts the positive charge in Ach; second, about 5'A distant 
from the anionic site, the esteratic site which bindsl the 
carboxyl carbon atom of Ach. It has been shown that the 
anionic site contains at least one carboxyl group present 
probably in the glutamate component (Cohen et al., 1959). 
The esteratic site involves a histidine residue adjacent to 
serine (Bergmann et al., 1956). 
Most of the information on the active centre has been 
obtained using appropriate anticholinesterases. In the 
study of the esteratic site, radioisotopes (32p or 14c) of 
organophosphorus reagents were reacted with the purified 
enzyme, the labelled protein was hydrolysed and the radio-
active products were isolated and identified (Michel and 
Krop, 1951). The sequence glycine-glutamine-serine-alanine-
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glycine-glycine (Jansz et al., 1959) established for the ester-
atic site of ChE is typical and Cohen et al., (1955) hypothe-
size~ that a number of DFP-sensitive enzymes carry a similar 
structure which react with DFP, the radioactive organophos-
phorus residue being coupled with serine. 
Several models were suggested to explain hydrolytic ac-
tivity of AchE's as well as their inhibition. Bergmann et al, 
(1958) suggested that the acidic group in the esteratic site 
forms a hydrogen bridge with ethereal oxygen of Ach and is 
active in the hydrolysis of enzyme-substrate complex. Other 
model systems of Ach hydrolysis stresses the significance of 
serine hydroxyl activated perhaps by imidazole and of the 
carboxyl grouping (Cunningham, 1957; Fahrney and Gold, 1963). 
The serine hydroxyl and the carboxyl group may form an internal 
ester or carboxylate ion. This carboxylate nucleophilic center 
is capable of intra molecular attack on the carboxyl atom of 
the ester to produce rapidly hydrolysed anhydride. 
Anionic sites may be necessary with regard to inter-
action between the substrate molecule and ChE. Results obtained 
with bisquaternary inhibitors suggest (Bergmann, 1955) that 
anionic sites occur in pairs in the vicinity of the esteratic 
site and that they consist of the Y carboxylic groups of an 
y-gluta.myl peptide. It is by no means certain that quaternary 
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nitrogen of these inhibitors react with the same site as the 
cationic head of Ach; thus, the enzyme may contain several 
anionic sites. 
ISOZYMES OF ACETYLCHOLINESTERASE AND CHOJJINESTERASE: 
According to Markert and Moeller (1959), isoenzymes are 
enzyines which have the same catalytic action and are derived 
from the same organ, but have different chemical and/or 
physical properties. Many authors have pointed out (eg. 
Wieland and Pfeiderer, 1962; Kaplan, 1963) that the multiple 
molecular forms of an enzyme are only of significance when 
they do not arise as artifacts of purification. Dubbs (1966) 
disagrees with their viewpoint; he believes that a ChE isoenzyme 
which is observable after ultrasonic treatment of serum and not 
observable without such treatment is not a mere artifact but 
a significant entity. However, it is probably that an iso-
enzyme arising after ultrasonic treatment may be an artifact. 
Human serum cholinesterase has been separated electrophor-
etically (Dubbs et al., 196o; Bernsolm. et al., 1961, 1966) into 
at least seven distinct bands, each of which may be referred 
to as an isoenzyme (Webb, 1964). Juul (1968) employed disc 
electrophoresis of huma~ serum ChE; he identified twelve iso-
zymes. Almost 803 of the total ChE activity was pr.esent in one 
isozyme (chE7). In adrlition to electrophoretic separation of 
ChE isozymes, it has been possible to fractionate human serum 
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ChE into component isozymes by gel filtration on sephadex 
G-200 columns (Harris and Robson, 1963) and also by chroma-
tography on DEAE cellulose columns (Liddell et al., 1963). 
In a study of properties of ChE isozymes, Ecobichon and 
Kalow (1963) removed the sialic acid residues of human serum 
ChE and found that although electrophoretic mobility was 
affected, the kinetic properties of the product remain un-
changed. La Motta et al., (1965) demonstrated that five of 
the isozymes of human serum ChE are interconvertible and re-
present different stages of polymerization. La Motta et al., 
(1966) later were able to show that all seven serum ChE isomers 
are interconvertible polymers, each containing the same poly-
peptide unit. 
Barron et al., (1962) have separated the AchE of human 
brain into isozymes. Ecobichon and Israel (1967) found not 
only four isozymes of AchE but also two weak bands of ChE and 
one band of nonspecific carboxylesterase in the electric organ 
of electrophorus electricus. Massoulie and Rieger (1969) 
found three main molecular species (A, C and D) exhibited 
acetyl cholinesterase activity in the extract of torpedo 
electric organ. Thi.s was observed in fresh frozen organ 
extracts, toluene-autolyzed organ extracts, or autolysis 
exudates. The fourth species, B, appeared during autolysis 
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in the exudate. These species were found to be stable even 
after treatment with various drugs. Molecular species C and 
D show the phenomenon of aggregation in low salt concentra-
tion whereas A and B do not. 
Rieger et al., (1973) differentiated the several forms of 
AchE by their sedimentation constant and by their structure. 
They separated them into globular and elongated forms. Elonga-
ted forms were in turn separated into forms of various sedime~­
tation coefficient A (8,55), C (14.25), and D (18.45). By 
using different antibodies they found that the elongated forms 
were more reactive than the globular forms with each antiserum 
tested. Neuraminidase treatment decreased the affinity of 
antiserum for the D and C forms but not for the globular 
forms following treatment with neuraminidase. This would imply 
that polysaccharides are important for the structure of elonga-
ted forms. 
INTERACTION OF CHOLINESTERASE AND ACETYLCHOLINESTERASE WITH 
IRREVERSIBLE INHIBITORS: 
Enzyme inhibitors may be classified as reversible or 
irreversible. As used by enzymologist, the term reversible 
means that the inhibitory action may be reversed easily, e.g. 
by removing the inhibitor by dialysis. In the case of irre-
versible inhibitor, the inhibitory action is not easily reversed 
and the amount of inhibition will increase progressively until 
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the enzymatic activity is nullified, provided large a.mount 
of inhibitor is present. 
The most potent and well characterized irreversible in-
hibitors of ChE fall into three classes: Organophosphorus 
inhibitors, carbamates and organosulfonates. 
MECHANISM OF IRREVERSIBLE INHIBITION 
The degree of inhibition observed with an irreversible 
inhibitor depends on the rate constant of inhibition {Kl) 
---- E + I ~ E I 
The inhibitor cannot be recovered intact from an enzyme in-
hibited by an irreversible inhibitor. Irreversible inhibi-
tion has been shown to occur as a multistage process: a re-
versible formation of an enzyme-inhibitor complex is followed 
by an irreversible phosphorylation of the enzyme {"aging", cf. 
below). It is not true that enzymatic activity can never be 
recovered from enzymes inhibited with irreversible inhibitors. 
However, even though the enzyme may be recoverable {cf. below) 
the inhibitor is not recoverable. Thus, in the case of inhibi-
tion of ChE by the organophosphorus compound sarine followed 
by reactivation by pyridine-2-aldoxine methiodide (P-2AM), 
ChE activity is restored but the sarin moiety is removed 
from the E+I compound as phosphoric acid rather than as the 
phosphonofluoride. The acid is not a ChE inhibitor. 
p 
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REACTIVATION: 
Reactivation of irreversibly inhibited ChE is the process 
by which enzymatic activity is restored to the inhibited en-
zyme. This process may occur as the result of interaction 
with the solvent in which case it is referred to as spontaneous. 
Reactivation may also occur as the result of the action of some 
compound added to the reaction mixture for the purpose. For 
reactivation to be possible, the native structure of the enzyme 
should be retained through the inhibition and reactivation 
steps (Berendes, 1964). The phenomenon of aging in which 
the ability to reactivate the inhibited enzyme is lost as the 
result of a chemical or physical reaction, is discussed later. 
REACTIVATORS: 
Almost all of the presently known effective reactivators 
contain a quaternary nitrogen group separated from a reactive 
group by a distance which is approximately the same as the dis-
tance between the anionic and esteratic sites of ChE. The 
discovery of reactivators may be traced to the finding of 
Hestrin (1949) that intact AchE and hydroxamate are released 
upon incubation of acetylated enzyme with hydroxylamine. It 
was shown that, just as it can be acetylated, hydroxylamine 
can be phosphorylated by organophosphorus agents (Green and 
Saville, 1956) and that phosphorylation of reactivators 
follows their contact with phosphorylated enzyme which is 
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then reactivated (Wilson 1951, 1952). 
Among important factors in reactivation are the extent 
of the formation of protonated acidic sites, as indicated by 
relevant pH studies (Wilson et al., 1958) and the degree of 
nucleophilicity of the reactivator which depends upon the 
substituents on the hydroxamate or oxime anion. In 1959, 
Wilson suggested that a good reactivator could be .obtained 
by combining a nucleophilic group with suitably placed qua te!:-
nary nitrogen atom. These and previous findings led Wilson 
to development of monoquaternary pyridine aldoximes such as 
pyridine 2 aldoxime methiodide and pyridine 4 aldoxime methio-
dide (P-2AM and P-4AM). Wilson (1958, 1959) suggested that 
an ideal reactivator should be bound to the organophosphorus 
inhibited enzyme so that a nucleophilic grouping such as the 
oxygen should fall one cond length from the phosphorus atom. 
Reactivators are important not only for theoretical 
studies as they can be used in vitro but are also very prac-
tical in their applicability for the treatment of poisoning 
by anti ChE agents and for prophylaxis against such poisoning 
{Wills, 1963). 
AGING: 
Aging is a process in which inhibited enzymes become 
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refractory to reactivation. In the case of acetyl and cholin-
esterase an irreversibly inhibited. (e.g. phosphorylated) en-
zyme which can be at first reactivated by high concentrations 
of reactivator is transformed subsequently to a form that 
cannot be reactivated (Heilbronn-Wikstrom, 1965). At present, 
it is generally thought that aging depends on the change in 
the phosphoryl moiety (Jansz et al., 1959). Berendes (1968) 
postulated that the reaction involved in aging is due to hy-
drolysis of one alkoxy group f:·om pho.sphorylated enzyme: 
(OR) ro - E + HO ---7' (OR) (OH) ro E + ROH 
.l.. 
The evidence for this is as follows: 
In a normal reactivation process of DFP inhibited enzyme, 
32P was released as diisopropyl phosphate, whereas in an aged 
sample it was released as monoisopropyl phosphate by alkaline 
hydrolysis. The refractory portion of the phosphorylated 
enzyme was a hydrogen phosphate known to be resistant to 
nucleophiles (Heath 1961). 
Inhibition followed by aging.is an important and an 
useful mechanism which can be used to study the synthesis of 
AChE. The enzyme which arises following inhibition with DFP 
represents the newly synthesized enzyme. The irreversible 
inhibition can, therefore, be used to study the tlll'nover rate 
of AChE. From the amount of inhibited enzyme, ti~e taken for 
50% of the enzyme to be synthesised is determined. From the 
value, turnover rate of the enzyme was calculated. 
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INHIBITION OF ACETYLCHOLINESTERASE BY DFP 
WITH REVERSAL OF THE INHIBITION BY 2 PYRIDINE 
I AchEI 
I 
Serine 
I 
OH 
ALDOXIME METHIODIDE 
Esteratic site + 
J DFP 
29 
This diagram illustrates the irreversible inhibition of 
AchE by diisopropyl fluorophosphate as due to phosphor-
ylation of AchE through the serine hydroxyl present at 
the esteratic site. 
Cohen et al., (1955) 
i 
_J 
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+ 
I AchEI + 
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0-CH=NOH 
e I Ea N 
I 
CH3 
Pyridine 
2 Aldoxime Methiodide 
This diagram illustrates the reactivation of DFP inhibited 
AchE by pyridine 2 aldoxime methiodide. As a result of 
this process, the reactivator becomes phosphorylated. 
WILSON (1959) 
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DISTRIBUTION OF ACbE IN THE CENTPAL NERVOUS SYSTEM: 
l) Subcellular Distribution: 
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The cytological distribution of AChE in the central 
nervous system appears to resemble the pattern observed in their 
peripheral counterparts, in that the concentration is greatest 
at the membrane, ·while lesser concentrations of AChE are also 
present in the cytoplasm as well as along the length of the 
processes insofar as they can be traced. This could be demon-
strated histochemically (Fukada and Koelle, 1959). In frog 
nerve and brain, the highest activity of ACbE was found in the 
particulate fractions especially in the microsomes,in the 
membranous materials, less amounts of ACbE were found in the 
mitochondria (Clouet and Waelsch, 1961a,b). 
The type of cholinesterase found in tissue is often a 
reflection of the tissue. Neural tissue contains ACbE while 
non-neural tissue contains ChE. In the blood of most mannnals, 
erythrocytes contain only ACbE while plasma contains ChE 
(Zajicek and Datta, 1953). 
2) Tissue Distribution: 
Histochemical studies indicate that medulla, reticular 
formation, midbrain and caudate nucleus were those brain areas 
which exhibited highest. concentrations of ACbE (Holmes and 
Wolstencroft, 1964; Koelle, 1954 and 1963; Shute and Lewis, 
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l963). Primary efferent neurons were low in AChE. However, 
activity of AChE increased progressively in the tertiary and 
secondary sensory relay neurons. The cerebellar cortex of 
several ma..111Ilialian species and of the duck also contained 
AChE (Phillis, l965). Many AChE-containing fibers were found 
in cerebellar peduncle (cf. Karczmar, l969). In tissue culture, 
cortical AChE appeared to be presynaptic while glial cells from 
cortex and elsewhere in the brain contained ChE (Geiger and 
Stone, l962). 
In the cat retina, high AChE activity was confined to 
the innermost region of the inner nuclear layer and to a band 
extending from the inner zone of the inner plexiform to the 
outer part of the ganglion cells (Koelle et al., l952). The 
high staining in the cytoplasm of amacrine and ganglion cells 
seems to indicate that these cells are cholinergic. The four 
stained synaptic bands represent regions where the axons of 
amacrine and bipolar cells synapse with the dendrites of 
ganglion cells which might contain ACh as transmitter. Cells 
which are capable of responding to ACh and contain AChE, CbAC 
are considered cholinergic. 
In the auditory system highest concentration of AChE 
were noted in the neighborhood of the nerve chalices ter-
minating on the inner rows of hair cells and in the efferent 
nerve fibers of the olivochochlear bundle, oriented towards 
- ---- --·--·----
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the organ of Corti (Rossi and Cortesina, 1961). 
As this study deals with the properties of the nerve 
endings in the synaptosomal preparations, certain properties 
of the synaptosomes will be discussed below. 
PROPERTIES OF SYNAPTOSOMES: 
Preparation: During homogenization of the brain tissue 
in isosmotic aqueous sucrose, the central presynaptic nerve 
terminals seal off and form detached particles away from 
axons (Gray and Whittaker, l96o, 1962). Whittaker et al., 
(1964) called these detached particles "synaptosomes". These 
synaptosomes retain the morphological nature and chemical 
content of the intact presynaptic terminal (including the 
transmitter). By differential centrifugation they can be 
separated from other organelles (mitochondria, myelin) and 
provide a new type in vitro preparation particularly appro-
priate for neurochemical studies of neuronal function. 
Various types of central nerve terminals from various 
parts of the brain have been observed to :form synaptosomes 
during homogenization; for instance, the mossy fiber endings 
of the cerebellar cortex are a good source of syriaptosomes. 
The following discrete regions were shown to form synaptosomes; 
cerebral neocortex, hippoca.mpus, caudate nucleus (Laverty et al., 
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1963), spinal cord, hypothalamus (Michaelson et al. , 1963), 
and hypophysis (Labella and Sanwal (1965). Brain parts of 
various species such as the mouse (Weinstein et al., 1963), 
rat, guinea pig, rabbit, cat, dog and man (Siakotos) form 
synaptosomes during homogenization. However, the richly 
innervated peripheral tissues show a very low yield of 
synaptosomes. On subjecting the synaptosomes to osmotic 
shock, they may be further fractionated into soluble cytoplasm, 
::·ynaptic vesicles, external synaptosomal membrane and intra-
ter!"uinal mitochondria Morphological aI1d chemical ana.lysis 
of these fractions give a good picture of organization of the 
pre-synaptic terminal. Normally synaptosomes should be free 
of microsomes except those which arise during preparation. 
METHODS OF PREPAR!'\.TION: 
The methodology of the synaptosomal preparation is de- · 
scribed below (cf. Methods); a general outline will be pre-
sented at this time. Synaptosomes are osmotically sensitive 
structures. In isosmotic media, any kind of chopping, minc-
ing or dispersion of the tissue probably permits the survival 
of a considerable proportion of them as organized structures. 
Synaptosomes have sedimentation properties which are broadly 
similar to those c·.:' mitochondria and of the smaller fragments 
of myelinated axons, dendrites and glial processes formed during 
homogenization. 
, 
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The mitochondrial fraction obtained from sucrose homo-
genates of brain tissue by differential centrifugation is a 
mixture of all these components. Synaptosomes can be separated 
from myelin and mitochondria by making use of differences in 
equilibrium density in a sucrose density gradient. Myelin 
floats on 0.8M sucrose, whereas synaptosomes have an in~~­
mediate density (between mitochondria and myelin). In our 
study we used gradients of Ficoll made isosmotic with sucrose 
(Kurokawa et al., 1965). Electron microscopy analysis indi-
cates that these preparations are as intact as those obtained 
using sucrose as a density gradient; in some instances better 
respiratory activity of mitochondria was retained. Thus, a 
fraction rich in synaptosomes and essentially free from myelin 
and somatic mitochondria may be obtained by centrifuging a 
crude mitochondrial fraction in a five step discontinuous ficoll 
gradient consisting of 20%, 13%, 10%, 7.5% and 5% layers that 
have been allowed to diffuse into each other l~ hours before 
use. Flow chart for this isolation is shown in the Method 
Section. 
Once formed the synaptosomes are relatively labile struc-
tures; they are readily disrupted by variety of treatments, 
e.g. warming, vigorous mechanical agitation, supersonic vibra-
tions, detergents, freezing or thawing and hypo-osmotic treat-
, 
ment. Most of these treatments result in the prompt libera-
tion of soluble cytoplasmic components Hypo-osmotic disruption 
provides the most suitable procedure so far found for the isola-
tion of the constituent organelles of the synaptosome. Large 
number of synaptic vesicles survive intact, external membrane 
and intraterminal mitochondria are not unduly fragmented and 
can be separated from vesicles by centrifuging 
3) Morphological characteri~tics o~ synaptosomes: 
Synaptosome fractions can be prepared for electron 
microscopy by any of the standard methods of fixing, stain-
ing and embedding nervous tissue that gives a good preserva-
tion of nerve terminals in whole tissue blo~k. Electron 
microscopy method which we employed are discussed in detail 
in Method Section. 
In section, synaptosomes appear as membrane-bound, oval 
shaped bodies containing numerous vesicles and sometimes small 
mitochondria. Generally, sections of thickened membrane can 
be seen which are attached to the extra synaptic membrane; a 
• 
cleft at about 200A can be seen between the membranes. In 
addition, most synaptosomes contain a few larger vesicles and 
dense core vesicles. It is assumed that on homocenization 
the terminal region of the axon is pinched off and seals up 
to form a subcellular particle which carries with it a length 
r 
37 
of the characteristically thickened post-synaptic membrane 
of next cell. In viewing the EM picture, it must be kept in 
mind that even if all synaptosomes possess post-synaptic attach-
ments and mitochondria as well as synaptic vesicles, only cer-
tain planes of section will contain all three structural com-
ponents (Whittaker, 1963). 
IN VITRO USE OF SYNAPTOSOMES: 
The synaptosome as a pinched off cell process has within 
its external membrane, alcytoplasm containing a normal comple-
ment of glycolytic enzymes and one or more mitochondria. It 
thus may be regarded as a small, non-nucleated cell. Synapto-
somes have been used in vitro to study the synthesis, storage 
and release of transmitter (Krnjevic and Whittaker, 1965) and 
for sampling terminal axoplasm in studies of axonal flow 
(Barondes, 1966). Various workers (Austin and Morgan, 1967a) 
have used the synaptosomes for the investigation of the problem 
of the site of synthesis of axonal proteins, particularly those 
contained within membranous structures. 
Synaptosomes do in fact actively respire when warmed and 
provided with substrate~ They also synthesize high energy 
+ 
substrate, take up choline by a Na dependent Hemicholinium 
sensitive mechanism and possess a membrane with passive per-
meability properties similar to those of other non-royelinated 
neurons. Active transport have not been shown in synaptosoroes 
, 
so also depolarisation. DNA has never been found in synapto-
somes. Austin and Morgan (1967) found RNA in unfractionated 
and fractionated synaptosomes. 
ENZYMES: 
Synaptosomes in general host a number of enzyme systems, 
including enzyrnes responsible for synthesis and degradation of 
various transmitters, as well as enzymes concerned with pro-
tein synthesis. Synaptosome cytoplasm is believed to contain 
a full complement of glycolytic enzymes. Enzymes of external 
synaptic membrane include cholinesterases and Na+K+-activated 
ATPase. Synaptic vesicles contain only one enzyme Mg++-activa-
ted ATPase in low activity (Hosie, 1965). 
TRANSMITTER CONTENT: 
Acetylcholine, noradrenaline,· dopamine, hydroxytrypta-
mine,Y'-amino butyrate and glycine are found in appreciable 
concentrations in any synaptosomal fraction. If the synapto-
somes were prepared from specific areas in the brain, they can 
be shown to be rich in one or two specific transmitters. It 
is now known that most cholinergic neurons in marrnnalian brain 
form part of great ascending system, the reticular activation 
system which terminates on cortical and striate neurons (Lewis 
and Shute, 1966). Th:Us 7oo/o of the total acetylcholine of the 
, 
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forebrain remains in a bound form on homogenization and much of 
it is recovered in the synaptosomal fraction. Glycine in the 
spinal cord and gamma amino butyrate in the cortex are strong 
contenders for the role of inhibitors. In the forebrain, they 
both show the type of distribution predicted for the transmitter 
of an inhibitory neuron (by electrophysiological studies). 
Further the amount of gamma amino butyrate in cortical synapto-
some preparations is ade~uate to sustain a transmitter role 
(Whittaker, 1968). 
PROTEIN" SYNTHESIS IN ISOLATED SYNAPTOSOMES: In vitro studies: 
The synaptosomal fraction of a mammalian brain is a use-
fUl in vitro system to study neuronal and synaptic f'unction, 
since morphological and biochemical evidences have shown their 
intactness and relative purity (De Robertis, et al., 1963; 
Whi:taker et al., 1964). They are intact and pure without 
contarnination from other organelles. They are intact and pure, 
the way a mixture of cells are. 
Synaptosomal preparations have been used in vitro to study 
protein synthesis. In studying protein synthesis in such sy-
stem, the misinterpretation of the results due to contamination 
from subcellular particles are microsomal, mitochondrial and 
bacterial components capable of protein synthesis should be 
eliminated. For this reason, specific protein synthesis inhibi-
tors are used. 
, 
Inhibitor or enzyme Mode of action 
DNAse 
RNAse 
Cycloheximide 
Chloramphenicol) 
Hydrolyses DNA 3'5'-phosphate 
does not affect mitochon-
drial DNA 
Hydrolyses ribosomal RNA but 
does not affect mitochon-
drial RNA 
Specific for eukaryotic ribo-
somal systems, but not mito-
chondria 
Tetracycline )Af~ects bacterial and mito-
Erythromycin ) chondrial systems 
Lincomycin ) 
Actinomycin-D Inhibits DNA-dependent RNA 
polymerase including mito-
chondrial polymerase 
Puromycin Inhibits brain ribosomal 
system 
Inhibits mitochondrial system 
40 
Reference 
Winters berger 
(1966) 
Roodyn et al. 
(1961) 
Ennis and Lubin 
(1964) 
Siegel and Sisler 
(1965) 
Clark-Walker and 
Linnane (1967) 
Winters berger 
(1966) 
Campbell et al. 
(1966) 
Kroon (1964) 
Specific inhibitors added to the incubation medium which con-
tains the labelled amino acid, inhibits protein synthesis 
arising due to specific organelles. For instance, cyclohexi-
mide inhibits the protein synthesis arising from the ribo-
som.al system whereas chloramphenicol will inhibit the protein 
synthesis of the bacterial and mitochondrial system. 
The work of Autilio et al (1968) showed that brain synap-
tosomal preparations are capable of incorporating amino acid 
into proteins in vitro. They ruled out the contamination by 
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bacteria, microsomes and mitochondria that may have been 
present outside the nerve endings by using specific inhibitors. 
Bacterial contribution to protein synthesis was excluded from 
the limited inhibition they found with chloramphenicol (25%) 
and also the short period of linear protein synthesis in synap-
tosomes compared with exponential rate of synthesis in bacteria. 
By using ribonuclease or by adding supernatant enzymes or mi-
crosomes, no alteration was found in the rate of synaptosomal 
protein synthesis. This excluded the contribution of extra 
synaptosomal ribosomes or microsomes to the protein synthesis . 
. 
Austin and Morgan (1967) demonstrate that labelled microsomes 
added during homogenization of brain tissue are not incorpor-
ated into the synaptosomal fraction. In addition, protein 
synthesized in synaptosomes sedimented differently in sucrose 
gradients from those synthesized in microsomes. As regards to 
elements within synaptosomes responsible for protein synthesis, 
they suggested that within the nerve ending particles, 75% of 
the radioactive protein may be synthesized outside mitochondria 
and 25% within mitochondria. These conclusions were reached 
following use of various inhibitors. 
Austin and Morgan (1967) studying a cell free synaptosomal 
preparation found that the rate of incorporation of 14c leucine 
was linear and decreased with age. 
F 
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120 
CP.M 90 
per mg 
of 
protein 
30 
1 2 3 4 
Rate of incorporation of leucine with animal age in months 
On the basis of the results obtained with protein synthe-
sis inhibitors, Morgan and Austin (1968) suggested that synap-
tosomes can be considered as an anucleated mammalian cell which 
exhibits two protein synthesizing systems. The mitochondrial 
system is sensitive to chloramphenicol and chloramphenicol-
like antibiotics tetracycline, erythromycin and lincomycin 
whereas the membrane system is sensitive to cycloheximide. 
Morgan and Austin (1968) found release of labelled fragments 
14 (following incorporation of C leucine) upon subjecting pre-
parations containing synaptosomes to osmotic shock. The only 
osmotically-sensitive structures in their preparation were the 
synaptosomes The release of material upon osmotic shock is 
therefore a good indication that the material originates from 
the synaptosomes. 
Bachelard (1966) suggested that protein synthesis in 
synaptosomes might be entirely due to the presence of synapto-
somal mitochondria which presumably transport protein via the 
soluble fraction to the membrane. Normally chloramphenicol 
should inhibit mitochondrial protein synthesis and should 
f 
prevent release of mitochondrial proteins to other fractions. 
As this did not occur with chloramphenicol in their work, a 
contaminated synaptosomal preparation may have been involved. 
Goldberg (1971) studied protein synthesis in mitochon-
dria and nerve endings and compared the incorporation of 
14
c-leucine under identical incubation conditions. He found 
that both fractions had similar requirements for sodium and 
potassium activation, with concentrations of lOOmM and lOmM 
respectively producing maximum levels of incorporation. He 
suggested that the mechanism of protein synthesis in nerve 
endings and brain mitochondria was similar and similar 
synthetic systems are present in the mitochondria and nerve 
ending fractions. 
EVIDENCE FOR AXONAL RNA: 
Despite the fact that the electron microscope has failed 
to reveal the presence of ribosomes within the axonal and 
synaptic regions of neurons, (Palay and Palade, 1955) there 
is evidence indicating that protein synthesis proceeds in iso-
lated synaptosomes. There must therefore be a specialized 
site and mechanism concerned with protein synthesis at the nerve 
endings. 
Evidence for the presence of RNA in the axon is readily 
available today. By using ultra microanalytical procedures, 
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Edstrom (1964) demonstrated RNA in the Mauthner axon of gold 
fish and in the lobster stretch receptor neuron at a concen-
tration of 0.05% (wt/volume). This concentration paralleled 
that found for the myelin sheath; high concentration of RNA 
were present both in the proximal and distal regions of the 
axon (cf. Tuble below). 
Content of RNA in 200 pl pieces of Mauthner axons and 
myelin sheaths from the gold fish (Edstrom et al., 1962) 
Method of extraction: 
0.4mg RNase/ml 
dist. water ~H-6.o 
3 hours, 37 C 
Control dist. water 
pH6.o, 3hrs. 37°C* 
Difference 
Experiment 1 
Formalin Fixation 
Myelin 
Axons Sheaths 
15.9 
38 
93.:t,10 
25.6 
68 
Mean values in )f}l-g.:t, S E. of the mean 
Experiment 2 
Carnoy fixation 
Axons 
30.9 
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*Either without.any added enzyme or with 0.4mg of ultraviolet 
inactivated RNase. 
The base composition of RNA in the axon and myelin sheath 
although variable differed distinctly from that of ribosomal 
RNA. On the other hand, the base composition of RNA in the 
cell body is similar to that of ribosomal RNA l.e. it is rich 
in guanine and cytosine. Edstrom et al., (1962) pointed out 
--------.~ . .._..,,,., ~~---------------------' 
p 
that this is compatible with the absence of ribosomes from 
the axons as determined by electron microscopy (Palay and 
Palade, 1955). 
The long period of time that a messenger RNA would need 
to traverse the length of long axons and reach the terminals 
would require a highly stable messenger to survive the trip. 
Thus Edstrom (1962) believes that protein synthesis ~n distant 
portions of the axon is not directed by messenger RNA which 
was made in the perikaryon and that there is evidence for 
local synthesis of RNA in axons. 
Koenig (1965) reported that denuded myelin free axons 
from the spinal accessory nerve of the rabbit contain RNA in 
concentrations far smaller than that found in Mauthner axon, 
that is, about 1/1000 as great as that of perikaryon. Koenig 
(1967) found also in vivo incorporation of 3H leucine into 
axonal protein and of ~-erotic acid and 3H-adenine into what 
he believes to be axonal RNA. Some of the latter material is 
degraded by RNase. Actinomycin did not inhibit leucine incor-
poration into protein while it inhibited precursor incorpora-
tion into RNA; this suggests local RNA synthesis (Koenig, 
1967). These results indicate that RNA and prot~in synthesis 
in axons might be a general phenomenon (Edstrom, ~962). 
r 
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This concept is supported by the data of Austin and 
Morgan (1967). They analyzed RNA in purified subfractions 
from rat cortex synaptosomes and found in unfractionated sy-
naptosomes 12 pg of RNA/mg protein; in synaptosome ghosts 
20 vg/mg protein; in the membrane subfraction E 14 µg/mg pro-
tein (subfraction E contains membrane fragments of microsomal 
dimension and some synaptic vesicles); in the subfraction F 
21 µg/mg protein (fraction F is believed to consist mainly of 
extra synaptic membrane and synaptosomal ghosts). The microso-
mal fraction contained 40 µg/mg protein. 
Koenig (1968) hypothesized that axonal membrane is omni-
potential .or omnivalent in terms of its functional properties 
as the information specif'Ying the characteristics of its protein 
is found throughout the membrane. It was postulated that tran-
slation of encoded information is controlled by local extra mem-
brane DNA dependent mechanisms which could either be extra or 
intracellular. According to Koenig, it should be possible to 
bring about a transduction of a given membrane region under 
proper conditions from one f\lnctional type to another. It 
appears altogether that there is strong evidence regarding the 
protein synthesizing capacity of synaptosomes and that it is 
likely that synaptic membranes synthesize their own protein 
and including the enzymes such as AChE. 
THE AIM OF THE RESEARCH PROBLEM 
One important element in the organization and f\lnction-
ing of the central nervous system is determined by the pattern 
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of synaptic connection between cells and the efficiency of 
such synapses in interneuronal communication. liiany of the 
electrical characteristics of synapses have been elegantly 
evaluated by electrophysiological techniques (Eccles, 1964). 
Yet, our understanding is still extremely limited as regards 
the biochemical events which may be rate-limiting in the intra-
cellular transfer of information. Proteins are obviously im-
portant with respect to the metabolism of neuro-transmitters, 
the structure of membranes of the nerve terminals and the 
synapses as well as with respect to other vital components of 
conduction as well as of the chemical transmission from one 
cell to another. An understanding of macromolecular metabolism, 
therefore, becomes critical for an understanding of synaptic 
:f'unction. To understand the metabolism of an important macro-
molecule like AChE at the synaptic junction is crucially im-
portant due to the specific role of this enzyme in transmission 
and as this knowledge may explain the general phenomenon in-
volved in the structurization of the synapse. 
The synapse may be considerably removed from the cell 
body and its nucleus. To meet its macromolecular require-
ments, the appropriate proteins must either be synthesized 
at the synapse or migrate from cell body to the synaptic 
junction. 
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It was shown in the classic study of Weiss and Hiscoe 
(1948) that after an application of a ligature around a nerve, 
the diameter of the nerve on the cell body side of the liga-
ture increased, whereas it decreased on the peripheral side 
of the nerve. Following the removal of the ligature the 
diameter of peripheral segment returned to normal at the rate 
1nun per day. The conclusion from those experiments was ines-
capably that there was a constant movement in a proximo distal 
direction and that any local th.L·ottling of the progress of that. 
movement resulted in the piling up of neuronal content. 
Weiss and Hiscoe (1948) proposed the phenomenon of axo-
plasmic flow or axoplasmic transport as the mechanism by means 
of which the nerve tissue located at·a distance from the cell 
bo~ receives various substances such as proteins and enzymes 
from the cell body following the synthesis at that site. 
The biochemical study of axonal flow by means of isotopes 
has become widespread and a wide body of information has been 
obtained with the use of labelled compounds. Following the 
injection of labelled amino acid Miani (1964) and Ochs (1966) 
examined a series of segments of a nerve at various intervals 
of time; progressive mi.gration of the labelled amino acid was 
demonstrated in these experiments. 
f 
49 
Using labelled amino acid, a rate of lmm per day has 
been observed for migration of labelled proteins down the axon 
(Droz, 1965; La.sek, 1966; Weiss, 1967). These experiments 
involved the peripheral nervous system. Barondes (1964) has 
postulated a similar axonal flow within the central nervous 
system. On the other hand, there are data suggesting that 
proteins may also be synthesized at synaptosomal sites 
(cf. above), and it is possible to infer that protein synthe-
cis occurs in synapses from the observation that brain slices 
incorporate radioactive amino acids into synaptosomal protein 
"rithout any appreciable time lag (Austin and Morgan, 1967). 
We undertook to study specifically the genesis of AChE 
in synapses in the central nervous system. As AChE is local-
ized at the external membrane of synaptic endings in choliner-
gic neurons, a mechanism must exist by means of which AChE 
could be either transported to or formed at this region with-
out hydrolyzing cytoplasmic ACh present presynaptically. 
Preliminary evidence was obtained in the peripheral system 
suggesting that the enzyme may be formed in the cell body and, 
then move down an axon; it may be possibly attached to neuro-
tubules acting as a carrier, (Ochs, 1963). On the other hand, 
evidence for local synthesis of the enzyme in axons has also 
been adduced (cf. above). These experiments were carried out 
with respect to peripheral nerve employing sectioning tech-
f 
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niques as well as anticholinesterases. Koenig (1965a,b) has 
been actively pursuing the study of axonal AChE synthesis. 
Cat bypoglossal and cervical sympathetic nerves and the bypo-
glossal nucleus were assayed for AChE on day 1,3,5 and 10 
after the administration of a high dose (4op. moles/kg I.V ) 
of DFP; the resynthesis of AChE following its inhibition by 
DFP with and vlithout axotomy was studied. Resynthesis of 
AChE was constant all along the various segments of peripheral 
nerve studied at each time interval. Koenig noted a loss of 
AChE from the perikaryon with a corresponding suppression 
of the somal synthesis dur~ng outgrowth of regenerating axon 
while the enzyme continued to be synthesized locally in the 
axon. The restoration rate of AChE activity in hypoglossal 
nerve following DFP was of order 7% per ~y. On the basis of 
these data, they proposed that axonal proteins which are syn-
thesized in perikaryon remain as constituents of axoplasm 
whereas axolemma.-bound structural proteins and enzymes such as 
AChE are synthesized by a local axonal mechanism. 
We undertook to study the genesis of AChE in synapses 
in the central nervous system. The problem to be investigated 
was whether AChE arrives at the terminal by axoplasmic trans-
port following its synthesis in the microsomes in the cell 
body or whether it is synthesized at the nerve endings. This 
study was therefore carried out to understand the mechanism of 
p 
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AChE synthesis in the nerve ending fraction. We pursued 
this study in rat brain by following the resynthesis of 
AChE after irreversible inhibition of the enzyme by DFP. 
Following the intracerebral injection of DFP, time was given 
to allow the DFP inhibited enzyme to age causing irreversible 
inhibition and new AChE synthesis was studied at various in-
tervals in various subcellular fractions. As in vitro model 
to study such a system, isolated synaptosomes (nerve-endings) 
and microsomes from 20 and 58 dn,y old .rat brain previously 
injected with DFP was chosen. 
If AChE is transported from the cell body following its 
synthesis at microsomes, there should be time lag following 
DFP in the appearance of the enzyme at nerve endings as com-
pared to the appearance in the microsomes of the cell body. 
If the nerve endings synthesized their own AChE, AChE activity 
in microsomes of the soma and in nerve endings would appear 
either simultaneously or it might be seen earlier at nerve 
endings than in the microsomes. Electron microscopy has 
failed to reveal the presence of ribosomes within the axonal 
and synaptic regions of neurons (Palay and Palade, 1955). 
The axon contains no morphologically identifiable protein 
synthesizing system. The nerve terminals at the end of axons 
are also devoid of identifiable ribosomes RNA have been shown 
to be present in the synaptosomal fraction (Austin and Morgan, 1967). 
f 
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Normally synaptosomes do not contain microsomes except as a 
conta.ri1inant. By making proper corrections, effect arising 
due to this was eliminated. Our data provide evidence for 
the synthesis of AChE at nerve endings in 20 and 58 day old 
rat brain following inhibition of the enzyme with DFP. 
The effect of Triton X-100 on the nerve ending and micro-
somal AChE was also studied. As the Triton X-100 released the 
meinbrane-bound enzyme, this would give some results as to the 
effect of DFP on the membrane-bound enzyme AChE. 
The turnover of rr~crosomal and nerve ending AChE iso-
enzymes was studied following inhibition with DFP. From the 
percent of enzyme synthesized over a pierod of days following 
DFP, the percent of enzyme turned over per day was calculated 
(i.e. turnover rate). The gel electrophoretic pattern of 
isoenzymes following DFP was scanned and the individual isoen-
zyme value was compared against the scanned control value. 
From these values, turnover rate of each isoenzyme was deter-
mined. The isoenzymes may be localized in different cell 
membrane and structures. The turnover study would indicate 
their localization and functional role of these molecular 
species. 
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In understanding studies of this nature, the misinterpreta-
tion of results due to various contaminants (from different 
organelles) should be eliminated. It is difficult to assess 
for contamination as there are no specific markers for synap-
tosomes; however, contamination can be evaluated by studying 
possible contaminating components of the preparation (cf. above) 
the only contamination encountered was due to microsomes 
(primary protein synthesizing machinery of the cell). The 
synaptosomes isolated at various time intervals were assayed 
for NADPH dependent cytochrome C reductase (microsomal marker 
enzyme) and corrections were made relative to this marker. 
Another misinterpretation of the results might arise 
because of the contamination of the synaptosomes by non-
neuronal elements such as glial cells. As glial cells con-
tain mostly cholinesterase, the values were corrected using 
suitable inhibitors. 
There is 20 percent contamination from membranes of 
unkno-vm origin. As results are obtained by comparing the 
values with control group (prepared in a similar way to drug 
treated group), the error due to membranes of unknown origin 
was reduced The difficulty in using Ficoll is its varia-
bility from batch to batch which varies depending upon the 
ion concentration and particle flux. To study ion flux, it 
was necessary to remove the high salt content by dissolving 
the Ficoll in a small arnount of water and reprecipitating it 
from 95% ethanol. The ethanol was removed by lyophilization 
for prolonged periods of time. In this case also, differences 
were eliminated by comparing the values of drug treated animals 
with those of control aniina.ls. 
, 
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MATERIALS AND METHODS: 
Male Sprague Dawley derived rats, 16, 20 and 58 days 
of age were used in these experiments. All animals were bred 
and raised at the appropriate facilities of the animal house 
at Veterans A&ninistration Hospital, Hines, Illinois. 
Diisopropyl phosphofluoridate (DF.P) was obtained from 
Sigma Chemicals. cl4 labelled DFP was obtained from New 
England Nuclear Corporation (lpc/ljllllole). Working standard 
was prepared fresh in propylene glycol for each group of 
injections. 
In early experiments with c14 labelled DFP, 10/..1 DFP 
containing 2pc was administered intracerebrally under ether 
anasthesia to 20 day old rats. A 10µ1 Hamilton microsyringe 
filled with known volume of labelled DFP was injected at the 
predetermined positions. Each time the needle was inserted 
to a marked region (i-11). Prior to all DFP injections, the 
rats received 6mg/kg of atropine methylnitrate intraperiton-
eally. 
At various time intervals, the rats were killed by de-
capitation. A 103 homogenate of the brain was prepared in 
0.32M sucrose in 25mM Tris, pH 7.5. A known amount of homo-
genate was solubilized with a solubilizer (phase combining 
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system, PcsTm, obtained from G.D. Searle and Co., Arlington 
Heights, Illinois) and was transferred to a scintillation 
vial containing l5ml solution of premix P (98% PPO 2:5 
diphenyl oxazole + 2% PoPoP 1:4 bis - 2 (5 phenyloxazolyl) 
Benzene). Solution of premix P was made at a concentration 
of 5gms/litre of toluene. Premix P was purchased from 
Packard Co., Desplaines, Illinois. The amount of radio-
activity in the vials were determined on a Packard Tricarb 
liquid scintillation spectrometer model 3003. Two aliquots 
from the same fraction were used for AChE and protein deter-
minations. To determine the amount of radioactivity bound 
to the protein, homogenate was precipitated with 5 vols. of 
trichloracetic acid. After drying, the precipitate was 
dissolved in NAOH. Toluene was added to solubilize the 
precipitate and the resulting solution was transferred to 
a vial containing 15 ml of premix P solution and radioactivity 
was determined as described above. 
When a dose of l.5mg/kg DFP was used, the inhibition 
of AChE at various subcellular fractions was found to be 
insufficient (cf. results, Table III). A dose of 3.5mg/kg 
was used in subsequent studies in 20 day old rats. Control 
animals were given propylene glycol intracerebrally; the volume 
(lOpl) was identical to that employed for the injection of DFP. 
f 
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58 day old rats were anesthetized with pentobarbital 
(20mg/kg) 30 minutes following i.p. administration of atro-
pine methyl nitrate (6mg/kg). Animals were held to the 
stand with the help of strings and a longitudinal incision 
was made dovm the center of the scalp. Using a scalpel 
blade, sk~ll was cleared of muscle and connective tissue. 
With predetermined coordinates, a small hole was drilled 
using a hand drill containing 1/32" drill bit. lOp.l 
Hamilton Microsyringe filled with DFP at a dose of 2mg/kg 
were lowered through wax filled hole. The needle was in-
serted to a depth indicated by a mark, DFP injected in the vol-
ume of the hole innnediately filled with bone wax and the skin 
incision sutured with nylon. No antibiotic was administered. 
Similar surgical procedures were performed in control animals 
w~ich received propylene glycol instead of DFP. Due to survi-
val problem, the dose of 2mg/kg of DFP was used rather than 
3.5mg/kg. Following the DFP injections, animals were sacri-
ficed at various intervals of time. The cerebral hemispheres 
were excised and bathed in 0.32M sucrose buffer prior to homo-
genization. Excision was completed within 20 seconds follow-
ing sacrifice of the animal. 
FRACTIONATION PROCEDURE: The isolation of subcellular fractions. 
What follows is a diagram of the general procedure of iso-
lation of synaptosomes and microsomes (Autilio et al., 1968). 
FLOW CHART FOR ISOLATION OF SUB-CELLULAR FRACTIONS 
10% Homogenate (0.32M sucrose in 25mrn Tris adjusted to pH 7.5) 
Centrifuge 
lOOOxg for 10 minutes 
r--~~~~1--~~~, 
Pellet 
Supernatant washed with lOml of sucrose buffer 
e-centrifuged at 
OOOxg for 10 minutes 
Supernatant + Supernatant Pel et 
1 2 
(Nuclei, unbroken tissue fragment) 
Combined Centrifuge 
14,000xg for 15 minutes 
Sup~rnatant Pel~et 
3 (Crude mitochondria) 
(Resuspended in 0.32M sucrose in 25mrn Tris 
adjusted to pH 7.5 
Centrifuge 
15,000xg for 20 minutes 
Supernatant + Supernatant 
3 4 
Combines and 
centrifuged 
110,000xg for 
Pellet (mitochondria) 
Suspended in 0.32M sucrose in 
25mm Tris PH::.7.5.3ml/gm of 
75 minutes original tissue 
(used for synaptosome isolation) 
Supernatant Pel et Microsomes This fraction was layered on 
a Ficoll gradient 
r 
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The patterns of Ficoll gradient were as follows: 
5 ml of mitochondria in 0.3211 sucrose in 25mm Tris (Pfr 7.5) 
5 ml of 5% Ficoll in 0.32M sucrose in 25mm Tris (pH 7. 5) 
5 ml of 7.5% Ficoll in 0.32M sucrose in 25mm Tris (pH 7.5) 
5 ml of 10% Ficoll in 0.32M sucrose in 25mm Tris (pH 7. 5) 
5 ml of 13% Ficoll in 0.32M sucrose in 25rnrn Tris (pH 7. 5) 
5 ml of 20% Ficoll in 0.32M sucrose in 25mm Tris (pH 7. 5) 
The crude mitochondrial fraction on a Ficoll gradient was 
centrifuged at 25,000xg for 45 minutes in an IEC head SB-100. 
Five layers were visible after centrifugation; myelin being 
lighter was in the top layer and the denser mitochondria 
formed the lower layers. Synaptosomal fraction of inter-
mediate density was formed as two separate layers between 
7.53 and 13% Ficoll. As these two layers between 7.5% and 
13% Ficoll represented a good source of nerve ending frac-
tion (demonstrated by electron microscopy) they were pooled 
and analyzed. Synaptosomal layers were collected, diluted 
in sucrose buffer and centrifuged at 40,000xg for 30 minutes. 
The pellet obtained in the wash was rewashed in sucrose buffer 
to remove Ficoll. Each final pellet obtained from the various 
fractions (microsomes, motochondria and synaptosomes) was 
homogenized in sucrose buffer (0.4ml/g of original tissue) 
• 
and stored at -40 r until use. A known a.mount of these 
fractions were used for AChE assay, protein detennination, 
electrophoretic separation, triton extraction and electron 
microscopy. 
r 
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ELECTRON MICROSCOPY: 
The synaptosomal pellets were fixed for electron 
microscopy in 0.1.M phosphate buffered glutaraldehyde 
(3.125%). After overnight washing in 0.1.M phosphate, 
the sample was osmicated for 1 hour in 1% buffered osmium 
tetroxide in the dark, which was followed by dehydration in 
35%, 50%, 70%, 80%, 95% and absolute ethanol (10 min. each) 
at approximately 4•c. The sample was allowed to stand in 
propylene oxide for 20 minutes, in propylene oxide: Epon 
resin l) (1:1) for 45 minutes, in propylene oxide: Epon 
resin (1:3) for 45 minutes, epon for 1 hour and finally in 
epon for 8 hours. Finally, it was embedded in fresh epon 
• in electron microscopy capsules and heated at 65 C for 
48-72 hours. 
l) Epon employed for embedding had the following components: 
16 volumesl Epon (Epon is a glycerol based aliphatic epoxy 
resin of almost water white color and low viscosity.) 
10 Volumes dodecenyl succinic anhydride. 
9 volumes methyl nadic anhydride. 
0.6 volumes dimethyl amino methyl phenol (DMP 30). 
When Epon is cured with dodecenyl succinic anhydride, a 
rather soft block rt. sul ts, whereas when cured with methyl 
nadic anhydride and dimethyl amino methyl phenol, a very 
hard block is formed. To produce blocks of desired hard-
ness, various proportions of stock mixture was used. 
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PROCEDURE FOR ELECTRON MICROSCOPY: 
The Epon embedded pellets were sectioned with a Du Pont 
diamond knife on the servall Porter-Blu.~ ultra microtome 
MT-2. After the sections were placed on 300 mesh specimen 
grids, they were stained with 103 ethanolic solution of uranyl 
acetate and 0.28% of alkaline solution of lead citrate for 
two minutes in each solution with several rinses in between. 
Electron microscopic study was performed on RCA EMU-3H instru-
ment. 
TRITON X-100 E..~TRACTION: 
Known amounts (mg/ml) of synaptosomal and microsomal 
fractions were homogenized with equal volumes of 2% Triton in 
sucrose buffer, thus making the final concentration to 1% 
Triton. Solutions were stored at 4•c for 6 hours and then 
centrif'uged at 100,000xg for 30 minutes. The sediment was 
suspended in lm1 ~O. Supernatant and sediment were analyzed 
for enzymatic activity. 
ENZYMATIC ASSAYS: 
Acetyl cholinesterase (AChE) assays were performed by 
the method of Ellmann et al., (1961) using acetyl thiocholine 
iodide (2.6mM) as ~ubstrate (Sigma Chemical Company). The 
enzyme activity is measured by following the increase of 
yellow color produced from thiocholine when it reacts with 
dithio-bis-nitrobenzoate ion. It is based on coupling of 
r 
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the following reactions: 
Acetyl Thiocholine Enzyme Thiocholine + acetate 
Thiocholine + Dithiobisnitrobenzoate ~ yellow color. 
The yellow color is measured in a spectrophotometer at 412mu. 
The reaction with the thiol has been shown to be sufficiently 
rapid so as not to be rate limiting in the measurement of 
the enzyme and the concentrations used do not inhibit the 
enzymic hydrolysis (Ellma.nn et al., 1961). Corrections were 
made :for non-enzymatic substrate hydr.olysis. A linear rate of 
hydrolysis was obtained for first 10 minutes. The slope of 
the curve expresses the rate in absorbance units/minute. 
From the extinction coefficient o:f the yellow anion moles of 
substrate hydrolyzed were detennined Enzyme activity was 
expressed as specific activity; specific activity is equiva-
lent to umoles of acetyl thiocholine hydrolyzed per minute 
per mg of protein. Quinidine sulphate (1%) was added at the 
beginning of the reaction to inhibit cholinesterase (Ellma.nn 
et al. , 1961). 
Cytochrome C reductase was ~ssayed by the spectrometric 
method of Sottocosa et al., (1967). Essentially, the method 
involves the measurement of the formation of reduced cytochrome 
C in terms of the increase in optical density at 550m.u. The 
final concentration of cytochrome C was 1 mg /ml. · Rate was 
linear for the :first minute and declined after 40% cytochrome 
C was reduced. Rate of cytochrome C reduction was calculated 
f 
from linear portion of the curve. Increase in O.D. at 550mµ 
per mg of protein per minute was used for calculating the activity 
The protein was determined by the method of Lowry et al., 
(1951) using bovine serum albumin {Pentex, Kankakee, Ill.) as 
standard. 
ACRYIAMIDE GEL ELECTROPHORESIS: 
When subjected to electrophoresis in acrylamide gels, a 
complex misture of proteins divides up into number of well 
defined zones or bands {Ornstein and Davies, 1964 ). Acryla-
mide gels have the great advantage of providing an uncharged 
matrix in which separation based on molecular sieving and 
mobility differences can be carried out. The ability of 
molecules to pass through a sieve depends on the size and 
shape of the holes in the gel, the size and shape of the 
molecules being sieved and interactions such as ion exchange 
which may occur between the molecules and matrix of the gel. 
Acrylamide gels used in these experiments are long 
chain molecules with varying proportion of cross linkages 
resulting from the addition of a proportion of bisacryla-
mide before polyme1ization. 
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A set of three gels were used in the separation, the 
sample, the spacer and the separating gel. These three gels 
provided a better separation of the sample. In the case of 
sample and spacer gel, the polymerization of acrylamide was 
achieved by the addition of riboflavin. Solution of acryla-
mide and riboflavin illuminated by an ultra violet light brought 
about the gel formation. Gels were formed after exposing the 
solution (acryla.mide + riboflavin) to ultra violet light to a 
pre-determined time. 
In the case of separating gel, polymerization of acryla-
mide was brought about by the addition of ammonium persulphate. 
The sample and spacer gel are characterized by a large pore 
size and different buffer system as compared to the separating 
gel with a small pore size. The sample applied on the sample 
gel concentrates sharply at the gel interface due to difference 
in buffer system and pore size (between the separating and 
sample gel). After this process is completed, the concentrated 
sample separates into the isoenzymes as they migrate through the 
small pore gel. The greatest advantage of this system is that 
it permits the concentration of the sample from a relatively 
large volume. 
PROCEDURE FOR POLYACRYLAMIDE GEL ELECTROPHORESIS: 
Polyacryla.mide disc electrophoresis was performed in a 
Canalco apparatus according to the method of Davies (1964) 
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as modified by Juul (1968) using glass tubes (I.D) 5nnn, length 
68mm, containing 1ml of separating gel. The composition of 
the various gels are shown below. 
SAMPLE GEL: (lOOml) consisted of 2.5gm acryla.mide, 0.25gm of 
N.N. methylene bis acryla.mide, 0.063ml of N:N:N:tetramethylene 
dia.mine, 20 gm of sucrose, 0.63 mg of riboflavin, 6.3 ml of 
IN HCl, and O. 69 gm of Tris hydro.xyamino methane. The pH of 
the final solution was adjusted to pH~5.8. 
SPACER GEL was identical in composition and pH with sample 
gel, except that sucrose was added in the amount of 30 rather 
than 20 gm. 
SEPARATING GEL (lOOml) was made with 9 gm acryla.mide, 0.16 gm 
N:N methylene bis acryla.mide, 0.03 ml N:N:N:N tetra.methylene 
dia.mine, 10 gm sucrose, 0.075 gm ammonium persulfate, 6.3 ml 
INHCl, and 3.75 gm tri-hydro.xy amino methane. The pH of the 
final solution was adjusted to 8.7. 
All che,"11.icals for electrophoresis were from Canal Indus-
tries Corporation, Maryland. 
The actual procedure for electrophoresis was as follows: · 
r 
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The separating and spacer gel following polymerization were 
kept at 4'c for 20 hours. The sample gel carrying ACbE-con-
taining sample (synaptosomes or microsomes) was polymerized 
prior to electrophoresis. Normally 50-75 p.g of protein was 
applied to each gel. Electrophoresis was performed at 3 ma 
• per column for 3 hours at 4 C using Tris-glycine buffer at 
pH 8.0. The gels were recovered from each glass tube by , 
rinnning individual tube with a jet of water After removal, 
each gel was incubated for 30 minutes in 15 ml of l/15M phos-
phate buffer, pH=-6.l, containing O.OJJ.1 glycine, O.OOJJ.1 euso4 , 
" . 0.03M Na2so4 at 25 C. Final incubation was performed in the 
same buffer containing 3xl0-5M acetyl thiocholine iodide for 
90 minutes. Both preincubation and incubation solutions 
included suitable inhibitors when required. The inhibitor 
was ambenonium mytelase; N:N'Bis, 3 diethylamine ethyl oxa-
mide bis 2 chlorobenzyl chloride which inhibited ACbE at a 
concentration of 5xl0-~; this inhibitor was used to differ-
entiate the acetyl-and cholinesterases. After the enzymic 
reaction had proceeded sufficiently, the gels were then trans-
ferred into 3M (NH4)2S04 saturated with dithioxamide to fix 
the enzyme and were allowed to stand at 4c for 24 hours. 
Destaining was accomplished with 7% acetic acid. The gels 
containing the stai: ed isoenzymes of microsomes and synapto-
somes were scanned in a Canalco model T microdensitometer 
without a filter to determine relative distribution of ACbE 
activity in the various isoenzymes. 
70 
For heavier and weaker bands, the settings were 20 mm2 
and 4 nnn2 per integration respectively. The base line was 
established at anodal end. The percent of each peak was cal-
culated from the total integration of all peaks. 
From the specific activity (AChE) of the applied sample 
and from the percentage of each peak, relative specific ac-
tivity of each isoenzyme band was calculated. Microsomes and 
synaptosomes from control and DFP treated rats were analyzed 
for isoenzymes in this manner. By comparing the relative 
specific activity of the isoenzymes of the control group 
with that of DFP treated group {rats), the percent inhibitions 
of microsomal and synaptosomal isoenzymes were calculated. 
The relative rate of the return of enzyme activity of micro-
somal and synaptosomal isoenzyme with time was measured by 
analyzing and comparing the values of various groups of DFP 
treated rats with control rats. By subjecting the values from 
various animals to computer analysis, the standard error of 
the mean was determined. 
f 
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RESULTS: 
The purified rat brain synaptosomes or nerve endings 
obtained by using a discontinuous Ficoll gradient are shown 
in Figure 1. Bands B and C represent a compact mass of in-
tact nerve endings. 
The combined Band C fractions layered between 7.5 and 
13% Ficoll in a Ficoll gradient represent the synaptosomal 
or nerve ending fraction. The combined fractions were 
analyzed by electron microscopy; a typical electron micro-
graph of these fractions is shown in Figure 2 and 3. Synap-
tosomes can be expected to contain the organelles present 
presynaptically (intraterminal mitochondria and vesicles) 
and their post synaptic attachments. As demonstrated by 
electron microscopy our synaptosomal fractions were found to 
be relatively pure; in most cases, the intact synaptosomes 
with their vesicles, intraterminal mitochondria and post junc-
tional complexes could be seen. Dark, ill defined fragments 
were also present; according to many investigators (cf. for 
instance De Robertis et al., (1963)) these fragments are the 
so-called synaptosomal ghosts and represent the synaptosomal 
junctions. This specialized junction associated with its 
organelles and particularly with the clumped presynaptic 
vesicles has been called by Palay (1958) "The synaptic 
complex". There is no direct evidence to prove that the 
FIGURE 1 Final stage of purification of 20 day old rat 
brain synaptosomes: the discontinuous Ficoll 
gradient, synaptosomal fraction sediments between 
7.5% and 13% Ficoll. 
-Figure 2: 
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Electron Micrograph of 20 day old rat brain 
Synaptosomal preparation 44,900 x magnification. 
1. Synaptic vesicles 
2. Large vesicles 
3. Coiled elongated mitochondria 
4. Dark Fragments (Junctional complex) 
Specimen fixed in glutaralde.byde and OS04 as 
described in methods. 
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Figure 3: Electron Micrographs of 20 day old rat brain 
synaptosomal preparation. 80,820 x magnification. 
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synaptic complex corresponds to the site where chemical trans-
mission takes place. This conclusion can be however extra-
polated from neurophysiological studies of intact synapses; 
moreover, indirect evidence indicates that the synaptic com-
plexes are the specialized zones of the neuronal membrane 
where the neurotransmitter is released at the presynaptic site 
and where the substance exerts the effects at the post synap-
tic site. Figure 3 represents the electron micrograph of the 
synaptosomal fraction under hipher magnification. The elong-
ated mitochondria, vesicles and post-synaptic attachment can 
be seen at higher magnification. 
STUDIES USING (c14)-IABELLED DFP: 
Initially it was intended to study the binding of (c14)-
DFP to various subcellular fractions and the turnover of radio-
activity at various intervals of time. For this purpose, DFP 
was administered by intracerebral injection so as to avoid its 
accumulation in fat depot which would occur following peripheral 
(i.v. or s.c.) administration. In the initial experiments, 
varying amounts of (c14)-DFP (l)lc/lumole) were injected intra-
cerebrally in 20 day old rats. The animals were sacrificed 
24 hours following the injection. A 10% homogenate of the 
rat brain in 0.32M sucrose buffer was made Cou~ts per min-
ute per total homogenate were determined. As can be seen in 
Table I, the radioactivity of the rat brain homogenate was 
increased with increasing a.mount of labelled compound 
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RECOVERY OF RADIOACTNITY IN THE RAT BRAIN HOfv40GENATE 
FOLLOWING INTRACEREBRAL INJECTION OF cl DFP 
Amount of Number of Time of sacrifice Counts per minute cl4DFP used rats following the per total 
@ 2. OJ.tc 
©I.4Jf 
@0. 8JfC 
counts in 
the liver 
@)0. 4J.JC 
@o.lJ.tc 
Table I: 
in_jection homogenate 
3 3 hours 63, 720±2580 
3 24 hours 41, 985±2095 
6 24 hours 19, 760±720 
6 24 hours 22, 270±1020 
4 24 hours 11, 340±450 
3 24 hours l, 708±100 
Varying amounts of Cl4DFP were injected by intra-
cerebral injection. Animals were sacrificed at 
various time intervals. 
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(1708 cpm for O.lrc to 41985 cpm for l.lipc). Total counts 
were .also determined in the liver in one set of experiment, 
the purpose of which will be discussed later. 
The recovery of radioactivity in the homogenate follow-
ing the injection of (c14)-DFP could be calculated from the 
values in Table I. The recovery of radioactivity was approxi-
mately 1% following various injections. Various attempts 
W3re made to improve the recovery. (c14)-DFP used in the 
experiment depicted in Table I was prepared in propylene gly-
col, emulsions were prepared in a number of different media 
so as to facilitate better binding of (c14)-DFP. The media 
used were peanut oil, saline (0.9%), albumin (10%) and un-
labelled DFP (6oµg). Varying amounts of (c14)-DFP were 
mixed with 10µ1 of the media described above and injected 
intracerebrally into 20-day old rats. Rats were sacrificed 
24 hours following the injection. Counts per minute in the 
total homogenate were determined (Table II). The percent 
recovery of radioactivity using various media were as follows: 
(c14)-DFP in propylene glycol 1.0% (calculated from the values 
in Table I) with unlabelled DFP 0.000193, peanut oil 0.00054%, 
saline 0.0023% and albumin 0.00933. It can be seen that using 
unlabelled DFP or r·~anut oil as a media reduced the recovery 
of counts in the homogenate following the injection. 
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EFFECT OF VARIOUS CARRIERS USED WITH c14 DFP IN THE 
RECOVERY OF RADIOACTIVITY FOLLOWING INTRACEREBRAL 
INJECTIONS 
A:'Aount of Time of Counts per minute 
C DFP used Carrier Sacrifice in total homogenate 
1. 8J.te (6) Unlabelled DFP 24 hrs. 7690 ± 1200 
1. 7J.JC (3) Peanut oil 24 hrs. 2028 ± 200 
1. 4).JC ( 3) Saline 24 hrs. 7326 ± 800 
1. OJJC (3) Albumin 24 hrs. 20, 472 ± 2000 
Table II: c14 DFP was injected intracerebrally with various 
carriers. Rats were sacrificed 24 hours following 
the injection. Counts per minute in total homogen-
ate was determined. Number in parenthesis indicates 
the number of animals used. Values are expressed 
as mean + S.E.M. 
---
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It was critical at this point to examine the distribu-
tion of (c14)-DFP (l.Opc) in the various subcellular fractions 
following the injections. Twenty-four hours following the 
injection, rats were sacrificed, brains from three experi-
ments were pooled and a 10% homogenate in sucrose buffer 
was made. Subcellular fractions were obtained from the 
homogenate by differential centrif'ugation. Distribution 
14 . 
of (C )-DFP with respect to total homogenate was deter-
mined. As can be seen in Table III microsomes, mitochondria 
and nerve endings carried 1.12, 1.07 and 0.004 percent of the 
counts respectively. The rest about 98% of the count was 
found in nuclear and soluble fractions. To ascertain the 
nature qf these counts and whether they were protein bound 
or not, these fractions were precipitated with TCA. Micro-
somal TCA precipitate exhibited 13% of the original counts 
'Whereas mitochondrial TCA precipitate exhibited 13% of the 
original counts whereas mitochondrial TCA precipitate ex-
hibited 23% of the original mitochondrial counts. 
We further explored the poor recovery problem, by 
analyzing the various subcellular fractions electrophoreti-
cally. Isoenzymes were cut from the gel and extracted with 
buffer. Counts per minute per each isoenzyme band were 
found to be few in numbers (approximately 20 cpm per band). 
It was clear from these results that DFP of higher specific 
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PERCENT DISTRIBUTION OF c14 IN VARIOUS SUBCELLULA 
FRACTIONS FOLLOWING INTRACEREBRAL INJECTION OF 
cl4 DFP 
percent compared to total homogenate 
Microsomes 1.12% 
Mitochondria 1. 07% 
o. 004% Nerve endings 
Nuclear Fraction 29. 3% 
·14 
Table III: Following C DFP injection, brains were pooled. 
Various subcellular fractions were isolated fol-
lowing differential centrifugation. Total counts 
in various fractions were calculated against the 
total count in the homogenate and percent distribu-
tion was calculated. 
, 
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activity was needed to provide greater absolute recovery 
and data needed for subsequent experiments. As we could 
not obtain DFP of the high specific activity needed and thus 
the problem of recovering sufficient counts appeared insol-
uble, our initial experimental design was altered. 
Initially, it was intended to study the loss of radio-
activity at various intervals in microsomal and in nerve 
ending fraction following (c14)-DFP injection. It was also 
intended to study the loss of radioactivity in various micro-
somal and nerve ending isoenzymes. Loss of radioactivity of 
microsomal and nerve ending fraction at various intervals 
would give an indication of the disappearance of (c14)-DFP 
or the new synthesis of AChE. (c14)-DFP was employed in 
these experiments at a pharmacological inactive dose, so 
that inhibition sufficient to establish the new synthesis 
was not produced. Our subsequent plan was therefore to use 
a high dose of non-labelled DFP and produce sufficient 
inhibition of AChE in various subcellular fractions. 
INHIBITION OF RAT BRAIN AChE BY DI-ISOPROPYLFLUOROPHOSPHA'IE 
IN VITRO: 
To estimate the dose of DFP needed to obtain the 
necessary inhibition, preliminary studies were carried out 
in vitro with rat brain homogenate. Equal amounts (5 ml) of 
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rA.t brain (20 day old) homogenate (1:10) were incubated with 
various concentrations (l0-3M to l0-8M) of DFP in propylene 
glycol for an hour at room temperature (Figure 4). AChE 
activity was determined at the end of the incubation. Per-
cent inhibition of AChE was determined from the enzyme activity 
of control incubated with propylene glycol. The curve was 
linear for the io-~ - 10-7M concentrations; l0-5M concentration 
induced almost complete inhibition (92%) and not much addi-
tional inhibition was obtained with higher concentrations. 
The in vitro inhibition of rat brain AChE was analyzed 
electrophoretically (Figure 5). The normal AChE isoenzyme 
pattern of control homogenate is shown in A. Four isoenzymes 
were found in the control homogenate following incubation 
with the substrate (acetyl thiocholine iodide). At a con-
-6 
centration of 10 M DFP, Band 4 was inhibited partially and 
a small amount of AChE was found in the region of Band 2. 
Bands 3 and 1 were inhibited almost completely. At the con-
centration of 10-5M, the isoenzymes were almost completely 
inhibited except for the presence of a light band at region 
-4 -3 4. The concentrations of 10 M and 10 M caused complete 
inhibition of all the molecular species of the homogenate 
(Figure 5). These results indicated that a l0-5M concentration 
of DFP causes a 92% inhibition of the AChE of the rat brain 
homogenate and almost a complete inhibition of the four iso-
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THE INHIBITION OF RAT BRAIN AchE BY 
01-ISOPROPYL-FLUOROPHOSPHATE IN VITRO 
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Figure 4: Equal amounts of rat brain homogenates were 
incubated with various concentrations of DFP for 
an hour at room temperature. Percent inhibition 
was determined from the enzyr~e activity of the 
control, incubated similarly. 
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Figure 5: 
Set A: 
Set B: 
Set C: 
Set D: 
Set E: 
Set F: 
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·~ 
·B c D E 
Acrylamide gel electrophoretic pattern of rat 
brain AChE, when the homogenate was incubated with 
DFP in vitro. Conditions were the same as described 
for Figure 4. 
Gel 1 - Control homogenate incubated with substrate 
Gel 2 - Incubated with substr~te and myetalase 
Homogenate incubated with 10-~ DFP. In all cases 
1st gel was incubated with substrate, 2nd gel with 
substrate and ambenonium (Myt~lase). 
Homogenate incubated with io-4M DFP Homogenate incubated with 10- M DFP 
Homogenate incubated with lo-3M DFP 
All incubations were carried out at room temperature 
for an hour. 
Homogenate incubated ~tlth io-3M DFP for 4 hours at 
room temperature. 
F 
enzymes separated electrophoretically. 
IN VIVO INHIBITION OF RAT BRAIN AChE BY DFP: 
In vitro, lo-5M DFP caused 92% inhibition of rat brain 
AChE. We chose a dose that by calculation - in terms of equi-
distribution of DFP - provided three times this concentration 
as the lower dose for the in vivo studies (l.5mg/kg). Twenty-
day old rats were injected intracerebrally with various doses 
(l.5 - 4.0mg/kg) of DFP. Four hours later, the animals were 
sacrificed. AChE activity was determined in the 10% homogenate. 
Percent inhibition was determined from the enzyme activity of 
control an.imal injected intracerebrally with propylene glycol. 
As sho~m in Figure 6, inhibition varied from 76% at l.5mg/kg 
to 95% at 4.0mg/kg. 
In vivo, l20Jlg of DFP (4.0mg/kg) was required to inhibit 
95% of brain AChE in a rat with an average weight of 30gms. 
In vitro, l8.4µg of DFP (l0-5M) inhibited 92% of brain AChE 
in a lOml brain homogenate (equivalent to l brain). These 
results show that to inhibit the enzyme in vivo, six times 
the in vitro concentration of DFP is needed. These results 
indicate the difficulties involved in inhibiting the AChE in 
vivo following injections at various doses. 
THE EFFECT OF DFP (l. 5mg/kg) ON MICROSOMAL AND SYNAPTOSOMAL 
. AChE IN l6-:00.Y OLD RATS: 
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INHIBITION OF 20 DAY OLD RAT BRAIN AchE BY 
Dl-ISOPROPYL- FLUOROPHOSPHATE INJECTED INTRACEREBRALLY 
1.5 2.0 2.5 3.0 3.5 4.0 5.0 6.0 
Figure 6: 20-day old rats were injected with various doses 
of DFP intracerebrally. Four hours following the 
injection, animals were sacrificed. loo/o brain homo-
genate in 0.32M sucrose (in 25mM Tris pH 7,5) was 
made and analyzed for AChE. Percent inhibition 
was determined from the enzyme activity of control 
animal injected in a similar kind of injection with 
propylene glycol. Values are expressed ~ S.E M. 
(Three experiments, 6 rats). 
F 
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THE EFFECT OF DFP (l.5mg/kg) ON MICROSOMAL AND SYNAPTOSOMAL 
AChE IN 16-DAY OLD RATS: 
The inhibition found with homogenates in vitro following 
incubation with DFP, does not indicate the degree of inhibition 
in the various subcellular fractions, so a series of experiments 
to determine this was carried out. Control animals received 
propylene glycol. AChE specific activity of various subcellu-
lar fractions of control and DFP treated rats was determined 
at various intervals of time. 
Table 4 lists the specific activity of AChE of micro-
somal and nerve ending fractions of control and DFP treated 
rats at various intervals following the injection. From the 
specific activity of control animals, the percent inhibition 
was calculated for the various intervals after the DFP injec-
~ion. The nerve ending and microsomal AChE were inhibited 
33.4 and 54.6 percent respectively 4 hours following the admin-
istration of DFP. Twenty-two days following the injection, 
i.e. in 38-day old rats {Table IV), the percent inhibition 
in nerve ending and microsomal enzyme was reduced to 1. 6 and 
32.3 percent respectively. As DFP causes irreversible inhibi-
tion of AChE, the enzymatic activity after DFP treatment 
could be accomplished only by the synthesis of new AChE. 
This percent activity thus represents the amount of newly 
synthesized AChE. Thus, for a period of 22 days, AChE ac-
tivity was found to be increased by 31.8% and 22.3% of nerve 
88 
ACETYL CHOLINESTERASE ACTIVITY OF MICROSOMES AND SYNAPTOSOMES IN CONTROL 
AND DFP (1. 5mg/kg) TREATED 16-DAY OLD RAT FOLLOWING INTRACEREBRAL INJECTIONS 
Age of 
the rat 
16 
23 
31 
38 
CONTROL DFP TREATED GROUP 
Numoer Microsomes Synaptosomes Days atter Number Microsomes Synaptosomes 
of rats (~p. activity) (sp. activity) injection of rats (sp. activity) (sp. activity) 
4 O. ll02 o. 090 1 4 0.050 0.060 
4 0.146 0.103 7 4 0.106 0.095 
4 0.188 0.124 15 4 0.120 0.115 
4 0.192 0.128 22 4 0.130 0.126 
Table IV: Sixteen-day old rats were injected with DFP 
(l-5mg/kg) intracerebrally and sacrificed at 
various time intervals. Acetylcholinesterase 
activity was determined in synaptosomes and 
microsomes which were obtained by differential 
centri:f'ugation as described in the text. 
Specific activity is expressed as micromoles of 
acetylthiocholine iodide hydrolyzed /min/mg 
protein. 
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endings and microsomes respectively over the initial 4 hour 
inhibition. As the recovery of synaptosornal enz;yme activity 
was faster than that of microsomal enzyme, it follows that 
nerve ending synthesis of AChE following DFP occurred faster 
than the microsor.ial synthesis. 
As shovm in the above experiment, the inhibition of 
subcellular fraction with a dose of l.5mg/kg was incomplete. 
This may have been due to several reasons, most likely to 
the multiple binding of DFP to various proteins other than 
AChE and proteolipids. It was decided therefore to saturate 
the system with a higher dose, so that a better inhibition of 
subcellular fraction could be obtained. 
In the pertinent set of experiments, a dose of 3.5mg/kg 
was administered through the intracerebral routes. Control 
rats were given appropriate volume of propylene glycol intra-
cerebrally. Both control and DFP treated rats were sacrificed 
at various intervals of time. Specific activity of AChE in 
various subcellular fraction was determined· Table V summar-
izes the microsomal and nerve ending specific activity of AChE 
of control and DFP treated rats at various intervals of time. 
The percent enzyme (AChE) inhibition of DFP treated rats was 
determined on various days with respect to the enzyme activity 
of control rats obtained on the same days. On the day of its 
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REGENERATION OF ACETYLCHOLINESTERASE IN SUBCELLULAR FRACTIONS OF RAT BRAIN 
FOLLOWING INHIBITION OF THE ENZYME BY DFP (3. 5 mg/kg) INJECTED INTRACEREBRALLY 
Age of Number 
the rat of rats 
20 6 
23 6 
25 6 
35 6 
Table V: 
IN 20 DAY OLD RATS 
CONTROL 
DFP TREATED GROUP 
Microsomes Synaptosomes Days Number Microsomes Synaptosomes (sp. activity (sp. activity after of rats (sp. activity (sp. activity ± S.E.M) ± S.E.M) injection ± S.E.M) ± S.E.M) 
0. 109±0. 002 0.0986±0.001 6 0.0263±0.0001 0.0399±0.0002 
0.145±0. 003 0.1027±0. 001 3 6 0.0618±0.0005 0.0478±0.0004 
0.187±0. 005 0.122±0. 002 5 6 0. 0974±0. 001 0.0864±0.0008 
0. 190±0. 004 0.120±0. 002 15 6 0.125±0. 003 0.104±0. 002 
20-day old rats were injected with DFP (3.5 mg/kg) 
intracerebrally and sacrificed at various time 
intervals after treatment with DFP. Control rats 
received propylene glycol. 
Subcellular fractions of brain were obtained by 
differential centrifugation and assayed for Acetyl-
cholinesterase activity. 
gpecific activity is expressed as defined in Table IV. 
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ad.l"fiinistration (4 hours follovring injection), DFP caused an 
initial inhibition of 76 and 60 percent in the microsomal and 
nerve ending AChE activity respectively. With time (15 days), 
the enzymic inhibition in microsomes and in nerve ending was 
reduced to 34.0% and 13.0% respectively. Thus, after a period 
of 15 days, AChE activity was found to be increased by 47.C/1/o 
and 42.03 of nerve endings and microsomes respectively over 
the initial 4 hour inhibition value. Again, this reduction 
in inhibition could be accomplished only by new synthesis of 
the enzyme. 
Synthesis of nerve ending AChE versus microsomal AChE 
following DFP is shown in Figure 7. In this figure, the en-
zyme activity in various subcellular fractions following treat-
ment with DFP was plotted against time. For each day, the 
percent of new synthesis was determined in the DFP treated 
rats from the AChE activity of control rats determined on the 
same day. It is clear from Figure 7 that the recovery of en-
zyme activity in nerve ending fraction was always higher than 
the recovery in microsomal fractions 
In the course of the above experiments, DFP was given 
during the period of rapid growth (myelin fo:nnation) at which 
time the enzymes are being formed rapidly. It was critical 
to differentiate the new AChE that occurs in normal growth 
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RECOVERY OF ACETYL CHOLINESTERASE IN SUBCELLULAR 
FRACTIONS FOLLOWING INTRACEREBRAL INJECTION OF 
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Figure 7: 20-day old rats were injected with DFP'at a dose 
of 3.5rog/kg. After decapitation, subcellular frac-
tions were isolated from the cerebral cortex at 
various intervals of time by differential centrif'u-
gation. Percentage of enzyme activity in microsomes 
and nerve endings representing the new AC.hE synthesis 
were determined on the basis of AC.hE activity of 
fractions from control rats isolated at similar 
time periods. The first point shows the enzyme 
activity 4 hours following DFP. (Values with S.E.M 
in Table V.) 
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from the AChE which is replacing the old inhibited AChE. 
The enzyme activity arising due to normal development was 
determined from AChE values of control rats (Table V). The 
values for AChE following DFP was corrected on the basis of the 
developmental data and the results are presented graphically 
in Figure 8. In this case the developmental AChE increment 
was subtracted from the enzyme activity of DFP treated rats 
at various intervals of time and the difference represents 
AChE synthesized to replace specifically the DFP inhibited 
AChE. As already stated, in 20-day old rats, DFP caused on 
the day of injection, an inhibition of 76% in the microsomal 
AChE activity as compared to control; a~er 15 days, inhibi-
tion was reduced to 34% as a result of replacement by newly 
synthesized AChE. For a period of 15 days, therefore, the new 
sy.µthesis of AChE in microsomes constituted 42% of normal 
values; finally, after correcting this latter figure for the 
ontogenic synthesis of AChE, the amount of AChE synthesized 
for a period of 15 days to replace the inhibited enzyme was 
16% ± 2% (Figure 8). 
Analogous data for the synaptosomal AChE was as follows: 
DFP caused an initial inhibition of 6cYfo in the nerve ending 
AChE activity four ho~rs following the injection; 15 days 
later, the enzymic activity was only 13% inhibited as com-
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Figure 8: Conditions as described in Figure 7 . To differ-
entiate the synthesis of enzyme arising due to 
normal development and the one arising due to 
inhibition with DFP. Corrections for normal 
developmental rise were made in the DFP treated 
rats and the initial point was extrapolated to 
Zero. 
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pared to controls {cf. Table V). After the corrections for 
normal developmental synthesis was made, it appeared that 
during a period of 15 days the synthesis of AChE arising to 
replace the DFP inhibited enzyme was 43% of the control values 
(Figure 8). Two pools of AChE were formed in DFP treated rats; 
one was developmental enzyme, another the enzyme synthesized 
to replace inhibited AChE. In control rats, only one pool of 
enzyme, that is the developmental AChE is being synthesized. 
As the two groups of rats were of same age, the increase in 
AChE synthesis in DFP treated rats seems to be related to the 
inhibition of AChE by DFP. This inhibition caused by DFP 
might have repressed the feedback inhibition, normally due to 
the accumulation of AChE thus resulting in an increased AChE 
synthesis. This increase may be regulated either at the nuclear 
or at the microsomal level. There could be an increase in the 
production of niRNA or protein. The increase in AChE in DFP 
treated rats might represent the developmental enzyme. At 
this point with results available, we are not able to distin-
guish clearly as to which pool of enzyme activity was increased. 
Altogether, whether corrected for normal development or 
not, the nerve endings showed higher percent of AChE synthesis 
as compared to microsomes following DFP treatment (Compare 
Figures 7 and 8); in fact, the corrected figure shows a more 
rapid rate of AChE synthesis in the synaptosomes as compared to 
microsomes. 
CHARACTERISTICS OF THE EFFECT OF PFP IN OLDER RATS (58 d.a.y): 
Various workers have demonstrated that protein synthesis 
occurs in isolated synaptosomal preparations. Austin and Mor-
gan (1967) studying protein synthesis in synaptosomes showed 
the rate of incorporation of (c14)-leucine as linear and 
decreased with the age of the rat (cf. Introduction). The 
question arises as to whether the nerve ending synthesis is 
associated with the normal development of the animal and 
ceases at maturity or is a phenomenon which occurs in all 
age groups. It seemed appropriate therefore to compare the 
synthesis of AChE after DFP in the nerve ending of older 
animals. A group of 58 day old rats were used for this 
study. As it was difficult to keep the older rats alive 
after the higher dose (3.5 mg/kg) of DFP, a dose of only 
2 mg/kg was given via the intracerebral routes. Control 
rats received intracerebrally the appropriate volume of 
propylene glycol. Rats were sacrificed at various inter-
vals of time following the administration of DFP or propylene 
glycol. The specific AChE activities of the microsomal and 
nerve ending fraction of the brains of both the experimen-
tal and control rats were obtained on days 1,5,11 and 20 
and AChE activity expressed as percent of controls. Figure 9 
shows AChE activity of microsomes and nerve endings as com-
pared to control values on days 1-20 following DFP adminis-
tration. As can be seen, 80% of microsomal AChE and 86% of 
the nerve ending AChE was inhibited on the day of injection. 
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RECOVERY OF ACETYL CHOLINESTERASE IN SUBCELLULAR 
FRACTIONS FOLLOWING INTRACEREBRAL INJECTION OF 
DFP (2.0 MG/KG) IN 58 DAY OLD RATS 
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Figure 9: 58-day old rats were injected with DFP (2.0 mg/kg) 
intracerebrally and killed at various intervals of 
time following the injection. Subcellular fractions 
were obtained by differential centrifugation and 
assayed for AChE. Percentage enzyme activity 
representing the new synthesis was determined from 
enzyme activity of control animal injected with 
propylene glycol. Each point in the curve repre-
sents the value obtained from 6 rats Values are 
expressed as ~ S.E.M. 
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Twenty-two percent of nerve ending AChE and 35% of microsomal 
AChE remained inhibited on day 20 a~ter DFP; as compared to 
normal values, 45% of the inhibited microsomal enzyme and 64% 
of the inhibited nerve ending enzyme was replaced by newly 
synthesized AChE. As in the case of younger animals, at all 
intervals after the administration of DFP the nerve endings 
always showed higher percent of replacement of the inhibited 
enzyme when compared to microsomes, and particularly between 
days 1 and 4, AChE of the nerve ending fraction showed a more 
rapid rate of synthesis as compared to microsomal AChE. 
The recovery of AChE following DFP injection was more 
rapid in 58 day than in 20 day old rats. In the case of 20 
day old rate, 47.0 and 42% of DFP inhibited enzyme was re-
placed by newly synthesized AChE at the nerve ending and at 
the"microsomes, respectively, after a period of 15 days. 
In the case of 58 day old rats, 64 and 45% of the DFP-inhib-
ited enzyme was replaced at the nerve endings and at the 
microsomes, respectively, during the same time period. 
(Figures 7 and 9, Table V). 
Furthermore, in 58 day old rats DFP caused on the day 
of injection an 80% inhibition of microsomal AChE and 86% inhib-
ition of the nerve endings enzyme, whereas in 20 day old rats 
DFP caused an inhibition of 76 and 60% inhibition in micro-
somes and nerve endings, respectively. Due to the constant 
need for AChE, particularly in the adult, marked inhibition 
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might alter the synthesizing mechanism resulting in a rapid 
synthesis. Except on the day of injection, in both age groups, 
the nerve endings always showed higher percent of enzyme re-
covery when compared to microsomes. The faster rate of nerve 
ending AChE synthesis following DFP inhibition both in young 
and older rats demonstrates that at least a fraction of AChE 
synthesis at the nerve endings is not an age dependent phen-
omenon. 
EF'FECT OF TRITON ON AChE: 
As AChE is a membrane bound enzyme, various procedures 
must be used to solubilize the enzyme. If the enzyme is 
bound in such a way that its active centers are directly 
available to substrate, then permeability limitations with 
respect to DFP and substrate will not apply. However, as 
the enzyme is present in intact organelles (microsomes, 
synaptic cleft), permeability limitations will be evident 
if the active center of the enzyme resides within such 
structures. To ensure that the substrate is available to 
the active site, we decided to solubilize the enzyme, with 
non-ionic detergent Triton X-100. 
Preliminary studies of the effect of Triton X-100 were 
conducted on human brain AChE. 2 gm of human brain was 
homogenized with 4 vols. of extraction media (0.9% NaCl or 
Triton X-100 (0.2-5.03) in o.9% saline solution). Following 
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centrifugation, supernatant and sediment was analyzed for 
AChE activity and values obtained with and without Triton X-
100 were compared. Effect of various concentrations of Triton 
X-100 on the human brain AChE activity is shown in Table VI. 
There is redistribution of protein between supernatant and 
sediment, and solubilization of more than 50% of the protein 
when the concentration of the Triton X-100 is increased from 
0 to 5.oo/o. Despite the loss of protein in the residue, the 
total AChE activity remains virtually constant in the residue 
at Triton X-100 levels of 0.2 to 2% and only at 5% level does 
some inhibition of activity appears to occur. "Relative" 
specific activity was expressed as the specific activity which 
was arbitrarily set at 100. At 1% Triton X-100 levels, the 
relative specific activity value of the supernatant was in-
creased to 36o, with little change in relative specific 
activity of the residue. At 2.0% and 5% Triton X-100 con-
centration, the relative specific activities were 230 and 120, 
respectively. Without a conconunitant loss of enzyme activity 
in the residue, the increase in supernatant enzyme activity 
indicates the activation by Triton X-100 of AChE or release 
of bound AChE which was not normally available to the substrate. 
There was also an increase in the total enzyme activity. 
It was important to rule out that the effect (increase 
in AChE) observed by Triton X-100 was not due to the effect 
of Triton X-100 on the enzyme substrate reaction rather than 
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EFFECT OF TRITON X-100 ON • BRAlN ACETYLCHOLINESTERASE ACTIVITY 
Extractive Volume of Total protein ( mg) Total enzyme Relative * * Total enzyme 
sample (ml) activity (units}* spec. act: activity (units) 
Residue Supernatant Residue Supernatant Residue Supernatant Residue Supernatant Supernatant + residue 
Saline 0.9% 13. 4 9. 5 154. 2 23. 7 2. 0 0. 30 100 100 2. 30 
Triton X-100 0. 2% 13. 2 9.6 150. 5 36. 5 2. 0 0. 98 93 260 2. 98 
Triton X-100 0. 5% 13. 3 9.2 148. 9 43. 2 2. 0 1.19 87 280 3.19 
Triton X-100 1. 0% 13. 0 8.6 126. 0 67. 0 1. 9 2.18 93 360 4. 08 
Triton X-100 2. 0% 14. 3 8.9 127. 2 82. 7 2.1 1. 94 106 230 4. 04 
Triton X-100 5. 0% 14.2 8. 8 78.1 113. 5 1. 4 1. 36 106 120 2. 76 
*µmoles acetylthiocholine iodide hydrolyzed/min per ml solution. 
**Saline values arbitrarily set at 100 where spec. act. = moles acetylthiocholine iodide hydrolyzed/ min per mg protein. 
Table VI: Human brain, 2 gm, was homogenized with 4 vol. 
of extraction media (0.9"/o NaCl or the appropriate 
Triton X-100 concentration )0.2-5.0%) in a saline 
solution) and incubated for 30 minutes at 4*c and 
centrif'uged at 100,000xg for 1 hour. The sedi-
ment was dissolved in 12 ml of water. The super-
natant and sediment were analyzed for AChE activity 
as described in Methods. 
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to the solubilization of the enzyme. The effect of Triton 
X-100 on the ACbE assay system therefore was studied. This 
system contained soluble saline-extracted enzyme. Various 
concentrations of Triton X-100 were added to the reaction 
mediur.i, containing saline extract of human brain ACbE and 
acetyl thiocholine iodide. With various concentrations of 
Triton X-100 in the enzyme-substrate medium neither the 
residue nor the supernatant showed any significant changes 
in ACbE activity. The specific acti~ity of the residue and 
supernatant were approximately 2.0 and 1.0 respectively at 
all detergent (Triton X-100) concentrations. Thus, Triton 
X-100 per ~ does not appear to have any effect on enzymic 
activity after the enzyme is extracted. (Table VII) 
The activation of ACbE brought about by Triton X-100 · 
may be due to the release of the enzyme from its association 
with membrane fragments in varying degree or to the unmasking 
of the hidden catalytic sites. It is possible that Triton 
X-100 may open up active sites which are not normally avail-
able for substrate and are hidden in the membranes. 
EFFECT OF TRITON X-100 ON THE DFP INHIBITED ACbE: 
With the background of information obtainer. as to the 
effect of Triton X-100 on human brain ACbE, we decided to 
study the effect of Triton X-100 on the DFP-inhibited en-
zyme. The purpose was to examine the effect of DFP on the 
EFFECT OF TRITON X-100 ON ACETYLCHOLINESTERASE ASSAY VALUES 
Residue 
Sample 
Saline residue 
+ 0. 2% Triton X-100 
+ 0. 5% Triton X-100 
+ 1. 0% Triton X-100 
+ 2. 0% Triton X-100 
+ 5. 0% Triton X-100 
Supernatant 
Spec. 
act. 2 (xlO ) Sample 
2. 0 Saline extract 
1. 9 + 0. 2% Triton X-100 
2.1 + O. 5% Triton X-100 
2.2 + 1.0% Triton X-100 
2. 2 + 2. 0% Triton X-100 
2. 2 + 5. 0% Triton X-100 
Spec. 
act. 2 (xlO ) 
1. 0 
1. 0 
1. 0 
1.1 
1.1 
1.1 
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Specific activity is expressed as µmoles acetylthiocholine iodide hydrolyzed/ min per mg protein. 
Residue contained· 7. 4 mg protein I ml. Supernatant contained 3. 4 mg protein I ml. 
Table VII: Conditions as described in Table VI. Various 
concentrations of Triton X-100 was added to the 
assay medium and values were compared to the 
control without Triton X-100. 
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membrane bound or Triton-extractable enzyme. By studying 
the effect of Triton X-100 on the DFP-inhibited enzyme, the pre-
sence of hidden or bound catalytic site would be revealed. 
Subcellular fractions from the brain of DFP (3,5 mg/kg) 
treated and control rats (20 day old) at a protein concentration 
of 1 mg/ml were homogenized with and without 1% Triton X-100. 
The supernatant and sediment obtained following centrif'ugation 
was analyzed for AChE activity. The combined specific activity 
of supernatant and sediment represents the total enzyme activity. 
The enzyme activity determined in the absence of Triton X-100 
represents the soluble AChE. The difference in amount between 
the total and the soluble enzyme activity represents enzyme 
released by Triton X-100, i.e. the bound enzyme. The per cent 
recovery at various times following DFP of the total enzyme 
activity of various subcellular fractions of brains of rats 
injected with DFP was determined with respect to the total 
enzyme activity of the control rat brains. It could be cal-
culated from the values in figure 10 that 4 hours after the 
inhibition of the total enzyme activity of the nerve ending 
was 51% while the inhibition of the soluble synaptosomal 
enzyme was 6o%. Fifteen days following the injection, the 
inhibition of the total enzyme activity was 1% while the 
inhibition of soluble AChE was 13.0%. 
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Figure 10: Microsomal and nerve ending fraction from DFP 
(3.5 mg/kg) treated 20-day old rats at a con-
centration of 1 mg/ml was homogenized with Triton 
X-100 to a final concentration of 1%. After incu-
• bating for 6 hours at 4 C, mixture was centrifuged, 
supernatant and sediment were assayed, percent enzyme 
activity was determined by calculating the values 
of Triton X-100 treated DFP fractions (activity of 
Triton X-100 treated sup + sed) against the Triton 
X-100 treated similar control fractions. Each point 
in the curve represents the value obtained from 6 
rats. Values are expressed as..:, S.E.M. 
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In microsomes on the day of injection the soluble and 
total AChE were inhibited 76% and 66% respectively. Fifteen 
days following DFP, the total AChE was found to be inhibited 
24% and the soluble AChE to 34%. 
On the first day following DFP, the difference in inhibi-
tion of the total enzyme as compared to soluble enzyme was 
around 10-12% in the case of both microsomal and nerve endings. 
This 12% might represent the AChE which is membrane bound and 
not accessible to inhibitors or it might represent the mem-
brane bound enzyme which is being newly synthesized. In other 
words, th~re was membrane bound AChE which was not inhibited 
by DFP. When this enzyme was released by Triton X-100, it 
diluted the inhibited enzyme, consequently, the activity 
value for the total enzyme was higher (or inhibition lower) 
than that for soluble enzyme. 
EFFECT OF TRITON X-100 ON THE DFP-INHIBITED AChE AND CONTROL AChE: 
We decided to study the effect of Triton X-100 on the 
microsomal and nerve ending AChE of control and DFP-treated 
rats at various time intervals. The effect of Triton X-100 on 
the microsomal and nerve ending AChE from the DFP-injected rats 
was compared with the effect on the microsomal and nerve ending 
AChE of control rats. 
Microsomes isolated as described under Methods were ob-
tained from DFP (3.5 mg/kg)-treated and control 20 day old rats 
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adjusted to a protein concentration of 1 mg/ml and treated 
with 1% Triton X-100. The difference in amount between the 
total enzyme activity and soluble enzyme activity repre-
sented the Triton X-100 released AChE or the bound AChE. 
It can be seen in figure ll that in the case of microsomes 
obtained from control rate, the soluble AChE of control micro-
somes increased whereas the Triton X-100 released enzyme de-
creased with the age of the animal. The specific activity of 
the soluble enzyme of control microsomes increased in 15 days 
from a specific activity of 0.109 to 0.190 whereas the specific 
activity of Triton X-100 released enzyme underwent a change of 
0.210 to 0.120 in the same time period. In the microsomes of 
control animal, the increases in soluble enzyme accompanied by 
a decrease in Triton X-100 released enzyine at various time in-
terval might reflect the release of the enzyme from the bound 
state (following its synthesis) to the soluble enzyme. 
In the microsomes of DFP-treated rats, the specific 
activity of soluble enzyme increased markedly from 0.0263 
to 0.125 for the period of 15 days. For the same period, the 
Triton X-100 released enzyme underwent a small or no change in 
specific activity (from 0.09 to 0.080). It appears that in 
DFP-treated rats, there is a faster rate of AChE synthesis 
as compared to control rats. There might exist an equilibrium 
between the Triton X-100 released enzyme and the soluble en-
zyme. The steady state of specific activity in Triton X-100 
released enzyme (AChE) may be due to occurrence of equilibrium 
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Figure 11: Microsomes from control and DFP (3.5 mg/kg) treated 
20-day old rats at a concentration of 1 mg/ml was 
homogenized with Triton X-100 to a final concentra-
• tion of l°/o. After. incubation for 6 hours at 4 c, 
the mixture was centrifuged at 100,000xg for 1 hour. 
The supernatant and sediment {dissolved in 0.5 ml of 
1120) was analyzed for AChE activity. Normal enzyme 
activity without the Triton X-100 was the soluble 
enzyme. The difference between the Triton treated 
and the soluble enzyme was named as tPe Triton 
released. 
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between the rapid synthesis of enzyme and it's rapid release 
into the soluble form. 
Nerve endings from DFP (3.5 mg/kg) and control rats 
(20 day old) at a protein concentration of 1 mg/ml were 
treated with 1% Triton X-100 in a manner similar to that de-
scribed for microsomes. The results showed that the a.mount 
of soluble and Triton X-100 released enzyme increased both in 
cc~trol and DFP-treated rats. In control rats, the specific 
activity of soluble enzyme of the nerve endings increased 
from 0.098 to 0.120 for a period of 15 days (Fig. 12). The 
Triton X-100 released enzyme for the same period underwent a 
change in specific activity of 0.110 to 0.18. In DFP-treated 
rats, the specific activity of the soluble enzyme of the nerve 
endings increased from 0.04 to 0.10 for a period of 15 days, 
whereas Triton X-100 released enzyme underwent a change in 
specific activity of 0.07 to 0.18. The significance of this 
increase in Triton X-100 released enzyme is not knovm. This 
enzyme might act as a reservoir. The main function of AChE 
is at the :nerve endings where it hydrolyzes the released AChE. 
It seemed appropriate to visualize the existence of a reserve 
pool of enzyme which could be used in time. 
TURNOVER OF ACETYL CHOLINESTERASE ISOENZYMES: 
Microsomal and nerve ending fraction of DFP (3.5 mg/kg)-
treated and control rats (20 day old) were treated with 1% 
Triton X-100. Supernatant obtained following treatment with 
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Days after Injection 
Conditions were same as described for figure 11 
except 1 mg/ml of nerve ending (synaptosome) 
preparation was used. 
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Triton X-100 was analyzed electrophoretically by polyacryla-
mide gel electrophoresis. By densitometric scanning, the 
percent contribution of each isoenzyme to total specific 
activity was determined in both groups. From the specific 
activity of AChE of the supernatant applied to each gel 1rela-
tive specific activity of each isoenzyme was determined. Per-
cent inhibition of various microsomal isoenzymes of DFP-treated 
rats were determined from the relative specific activity of 
microsomal isoenzymes of control rats. Figure 13A shows the 
4 isoenzymes of control microsomes and figure 14A shows the 
4 isoenzymes of control nerve endings. In microsomes, the 
isoenzymes 2 and 4 were prominent and denser, whereas in 
nerve endings isoenzymes 4, 3 and l were prominent and 
denser. 
B, C, D and E in Figure 13 represent the microsomal 
isoenzyme pattern of DFP-treated rats on day l, 3, 5 and 15 
following the injection. On the first day after DFP injection, 
the inhibition of microsomal isoenzyme 4, 3, 2 and 1 were 813, 
25%, 49% and 0% respectively (Table VIII). Fifteen days 
following DFP, the inhibition of isoenzyme 4 was 36% and of 
isoenzyme 2 - 25%. In the same period, inhibited isoenzyme 
3 was completely replaced by newly synthesized AChE. During 
the period of 15 days, 45, 25 and 24 percent of inhibited 
isoenzyme 4, 3 and 2 was replaced by newly synthesized enzyme. 
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Figure 13: Treatment of microsomes with Triton were done accord-
ing to the conditions described in Figure 11. 4o-50 µg of Triton 
treated supernatant was applied to each gel. Separation was 
achieved at 4•c in Tris-glycine buffer (PH~8.4) at 3ma per tube 
for 3 hours as described in Methods. Incubation and staining 
of the gel were performed according to the procedure described 
in Methods. Gel A: Triton supernatant of microsomes from con-
trol rats. Gel B:C:D:E: Triton supernatant of microsomes on 
day 1, 3,15 following intracerebral injection of DFP at a dose 
of 3.5 mg/kg in 20-day old rats. 
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ACETYL CHOLINESTERASE ACTIVITY (%) OF 1% TRITON X-100 
EXTRACTED MICROSOMAL ISOENZYME OF DFP (3. 5mg/kg) 
TREATED 20 DAY OLD RAT DETERMINED BY DENSITOMETRIC 
SCAN AS COMPARED TO TRITON X-100 TREATED CONTROL MICROSOM 
From Origin Band 4 Band 3 Band 2 Band 1 
Supernatant from 
triton treated 
microsomes 
Day 1 
Day 3 
Day 5 
Day 15 
18. 8 
33.8 
48.3 
64.2 
75 
89 
100 
51 
54 
59 
75 
100 
Table VIII: Triton treatment of microsomes and electrophoresis 
were perfonned according to the conditions described 
in Methods. Relative Specific Activity of each band 
was determined from the specific activity of enzyme 
applied to each gel. 
Percent inhibition of various isoenzymes of the 
DFP-treat~d group were determined from the Relative 
Specific Activity of various isoenzym.es of the con-
trol group. 
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These values indicate that the microsomal isoenzymes not only 
show differential rate of inhibition but also different order 
of synthesis. This might indicate a different turnover rate 
for these microsomal isoenzymes. 
The inhibition and recovery of nerve ending isoenzymes 
were also studied in a manner similar to those of the microsomal 
isoenzymes. Figure 14, shows the 4 isoenzymes of control nerve 
endings. Isoenzyme 4, 3 and 2 ~.,.ere pl','ominent and dense. Gel 
B, c, D and E represents the nerve ending isoenzyme pattern 
on day 1, 3, 5 and 15 following treatment with DFP. From the 
values of control rats, percent inhibition of the nerve ending 
isoenzymes were determined on the day of injection; the isoen-
zymes 4, 3, 2 and 1 were inhibited 83%, 30%, 4% and 82% respect-
ively (Table IX). Fifteen days following DFP injection, the 
inhibition of the isoenzyme 4 and l was 16 and 25 percent, 
respectively. Inhibited isoenzyme 3 and 2 were completely 
replaced by newly synthesized enzyme. The inhibited isoenzymes 
4, 3, 2 and 1 were replaced to the extent of 67, 30~ 4 and 57 
percent, respectively, during a period of 15 days. Here again 
the isoenzymes of nerve endings demonstrated different order 
of sensitivity to DFP and of the recovery rate indicating a 
different turnover rate. 
4 
3 
2 
1 
A 
-, 
B c D 
Figure 14: Conditions as described in Figure 13. 
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Gel A: Triton supernatant of nerve endings fractions obtained 
from control rats • 
. Gel B,C,D,E: Triton supernatant of nerve ending fraction 
isolated on days 1,3,5,15 following intracerebral injection 
of DFP at a dose of 3.00 mg/kg in 20-day old rat. 
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ACETYL CHOLINESTERASE ACTIVITY (%) OF 1% TRITON-X-100 
EXTRACTED SYNAPTOSOMAL ISOENZYME OF DFP (3. 5mg/kg) 
TREATED 20 DAY OLD RAT DETERMINED BY DENSITOMETRIC 
SCAN AS COMPARED TO TRITON.X-100 TREATED CONTROL 
From Origin 
Supernatant from 
triton treated 
synaptosomes 
Day 1 
Day 3 
Day 5 
Day 15 
Band 4 Band 3 Band 2 Band 1 
17. 0 
32.1 
52.7 
84.0 
70 
78 
88 
110 
96 
98 
100 
100 
18. 2 
38.2 
60.7 
75.4 
Table IX: Triton treatment of nerve endings and electrophoresis 
were performed according to the conditions described in Methods. 
Relative Specific Activity of each band was determined from the 
specific activity of enzyme applied to each gel. Percent inhibi-
tion of various isoenzymes of the DFP-treated group were deter-
mined from the relative Specific Activity of various isoenzymes 
of the control group, 
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DISCUSSION: EFFECT OF DFP ON RAT BRAIN AC.hE 
After attempting various methods of isolation of synapto-
somes and analyzing the fractions by electron microscopy, we 
chose the method of Autilio and Appel (1968) as the fractions 
obtained by this method were relatively intact. Synaptosomes 
are difficult to obtain as intact preparations due to various 
conta..'llinating membranous elements (from various organelles in 
nerve cells). As can be seen from the electron micrographs 
(Fig. 1, 2) we were able to obtain relatively intact p~epara­
tions. Indeed, even the f'unctional contacts between the pre-
and post-synaptic terminal can be seen, as are the intrater-
minal mitochondria. 
Synaptosomes are heterogeneous with respect to chemical 
composition. Synaptosomes derived from the whole brain or 
from cerebral hemisphere contain various transmitters and en-
zymes responsible for their synthesis and degradation. Synap-
tosomes contain relatively large number of enzymes; enzymes of 
the intra-terminal mitochondria, enzymes of the soluble cyto-
plasm and enzymes of the extra-synaptic membrane. It is diffi-
cult to assess for contamination as there are no ·specific markers 
for synaptosomes. Since our purpose was to study the protein 
synthesis in synaptosomes, we were concerned only with components 
which would complicate interpretation of the origin· of protein 
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synthesis. The only contaminating fraction with which we 
were concerned were microsomes. Assaying for NADPH-dependent 
cytochrome C reductase in the synaptosomal and microsomal 
fraction through various isolation procedures is indicative 
of the degree of microsomal contamination. The contamination 
was found to be less than 15.Q%. By using rotenone in the 
assay medium, we eliminated the results arising from the mito-
chondrial enzyme. (Table X). 
We noted a low recovery of radioactivity in earlier ex-
. periments using (c14)DFP. The radioactivity of the homogenate 
following injection with (c14)DFP increased with increasing 
amounts of (c14)DFP but the recovery was still low. The 
original compound (c14)DFP was in propylene glycol. Since 
propylene glycol is an inert solvent, various media were tested 
to improve the binding of (c14)DFP to the brain. As can ·be 
seen (Table 2), there was no improvement in the recovery of 
the counts when various media were employed. The low recovery 
of counts in various subcellular fractions indicated loss of 
radioactive counts following the injection. 
Jandorf and McNamara (1950) injecting(32P) labelled DFP 
intravenously into rabbits found that radio phosphorus was re-
tained in relatively large amounts by kidney, liver and lung, 
while brain and other organs retained very insignificant amount 
of label. The brain, while exhibiting high levels AChE had 
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TABLE X 
NADPH CYTOCHROME C REDUCTASE ACTIVITY OF MICROSOMAL AND 
SYNAPTOSOMAL FRACTIONS. SPECIFIC ACTIVITY IS EXPRESSED AS 
..GI!: 550/minute per mg of protein 
Microsomal Fraction 0.255 
Synaptosomal Fraction 0.025 
0.26o 
0.028 
0.250 
0.030 
0.250 
0.030 
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the least amount of radioactivity. Cohen and Warringa (1954) 
studying the fate of DFP in human body found that its metabo-
lism involved both protein binding and detoxification, about 
80% of (32P) was excreted in urine as diisopropyl phosphoric 
acid and about 20% remained bound to the tissue. DFP bound 
nonspecifically to tissue proteins show little dealkylation 
compared to DFP which was found to brain enzymes. DFP bound 
nonspecifically to tissue proteins was hydrolyzed after a few 
hours. 
14 During injections with (C )DFP, in one set of experi-
ments, we found large amount of radioactive counts in liver 
(Table 1). The liver radioactive counts may represent DFP 
lost in detoxification and in the course of nonspecific bind-
ing. Normally aging phenomenon following DFP occurs by the 
loss of one isopropyl group. In a uniformly labelled (c14)DFP, 
the aging phenomenon would result in a loss of 503 of the in-
jected label. There may be further loss of label due to" non-
specific binding of (c14)DFP to tissue proteins. The actual 
counts obtained by us might represent the label bound to acetyl 
cholinesterase. These may be the reasons for the low recovery 
of counts obtained. The low recovery of counts did not permit 
the determination of the binding of inhibitor to :ndividual 
isoenzymes. 
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In our later experiments, using unlabelled DFP, a minimum 
of 2.0 mg/kg of DFP was required by intracerebral injections to 
inhibit 92% rat brain AChE (in 16 day old rats). Studying the 
inhibition with rat brain homogenate in vitro, 10-~ DFP caused 
92% inhibition of AChE. In terms of concentration at least 
seven times the in vitro concentration of DFP was required 
.!!'.! vivo to inhibit the enzyme to the same extent. 
In a homogenate, the structures of the organelle may be 
ruptured resulting in a better reaction with the inhibitor. 
On the other hand, in an in vivo system, (intact system), higher 
a.mount of inhibitor will be required to reach the enzyme bound 
to the membranes (synaptic junction). Once the inhibitor binds 
the enzyme, the binding becomes irreversible. Before it reaches 
the enzyme, it might bind nonspecifically to tissue proteins and 
proteolipids or might be carried in the blood stream away from 
the injected organ for the purpose of detoxification. 
Another explanation for the requirement of high dose 
in vivo is related to the hydrolysis of the DFP by certain 
enzymes present in the system. Mazur (1946) observed that 
l0-2M DFP in the presence of serum produced a considerable 
C~ evolution from ~ bicarbonate medium and that similar 
results could be obtained with tissue extracts and found this 
is due to DFP hydrolyzing enzyme. Aldridge also reported the 
hydrolysis of paraoxan (E-6oo) by serum esterase. The high 
, 
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a.mount of nonsp~cific esterase, especially aryl esterase pre-
sent in the brain might hydrolyze injected DFP. 
PROTEIN SYNTHESIS AND AXOPLAS.MIC TRANSPORT: 
There are a number of indications from our studies and 
that of others that nerve endings can synthesize their own 
protein. 
The classic studies of Weiss (1943, 1947, 1959, 1967) 
have sho1m that a mass of neuroplasm material migrates down 
the axon at a rate of approximately 1 mm per day. Weiss 
proposed the concept of axonal flow as a mechanism for the 
transport of speciailized cell products from the central site 
of manufacture to peripheral destination. Lasek (1968) using 
autoradiographic and scintillation counting technique studied 
the distribution of 3ir-leucine injected into the cat dorsal 
root ganglion and ventral horn region of the rat spinal cord. 
Bates of axoplasmic transport up to lOOmm per day were found 
in the case of the motor neuron and of the dorsal root ganglion 
cells of the cat, respectively. Lasek proposed that two cate-
gories of axoplasm.ic transport may be distinguished, in one 
case, the materials mostly protein is transported from the 
cell body at a few millimeters per day, as observed by Weiss 
and his co-workers; in the other, the protein is transported 
~Tith a wide range of only a few millimeters up to 100 to 500 mm 
per day. Various theories have been proposed regarding the 
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mechanism of axoplasmic flow. None of them is finnly supported 
by experimental data. Weiss (1967) and Ochs (1963) proposed 
that axoplasmic transport occurs by peristalic movement and 
energy is obtained from periaxonal elements. Recent tissue 
culture suggests the presence of a protein which by change in 
configuration provide the necessary energy for transport. 
Borisky and Taylor (1967) found a protein associated with 
microtubules and filaments in mammalian brain and squid 
axoplasm which had a high affinity for colchicine. The role 
of this protein in transport is being considered. A survey 
of concentration of this protein in a variety of cell types 
showed that protein extracts and specifically the extracts 
of axoplasm were the richest source of colchicine binding 
protein which is presumed to be subunit of microtubules. 
(Shelanski and Taylor, 1970). It is a major soluble protein 
and may also exist in particulate form. Half life of this 
protein was shovm to be about 4 days. Therefore microtubules 
are influx rather than structural elements. It has been 
shown that this protein migrates with a slow component of 
axoplasmic transport. Although nerve endings do not charac-
teristically contain any identifiable microtubules, substan-
tial proportion of soluble component of isolated nerve ending 
fraction is microtubular protein. 
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Studying the axonal transport of cholinergic enzymes, 
(Fonnum et al, 1973) the estimated-rate for AChE was 430mm/24 
hours for vagus and 73mm/24 hours for the bypoglossal nerves. 
These rates correspond to the fast or intermediate rate of 
axonal flow. They also found that only small proportion of 
the enzymes (5-20%) were mobile and concluded that only a 
part of AChE in the vagus and hypoglossal nerve migrated. A 
retrograde transport of the enzyme was also demonstrated. 
The amount of enzyme transported this way, represented only a 
small portion of the total transport of cholinergic enzymes. 
If it was assumed that AChE was transported by a fast 
transport, there must exist a mechanism by which it is trans-
ported to the presynaptic membrane. Tubular protein which 
was considered to be involved in transport was found to 
migrate only with slow component of axoplasmic transport. 
Furthermore, nerve endings do not characteristically contain 
any identifiable microtubules. Fonnum et al (1973) found only 
a small percent of the enzyme being transported and retrograde 
transport was much lower than this. So there must exist a 
system for breaking down the enzyme at nerve endings. Lyso-
somes have not been shown to be present in the nerve ending 
fraction. A small amount of proteinase activity with a PH 
range of 5.3 to 6.9 was found at NE (Palladin and Belik, 1970); 
Whether the proteinase is responsible for the breakdown of 
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AChE in the nerve ending is not known. As the main function 
of AChE is at nerve ending, a higher percent of the enzyme 
should be expected to be transported if it was dependent on 
the cell body for its synthesis. Large amount of enzyme was 
found to be stationary. Axoplasmic transport of AChE still 
remains an open question. 
On the other hand, there is evidence for local synthesis 
of protein in the nerve axon as shown in vivo and E! vitro 
studies. T'ne recent extensive work with the unicellular 
organism Acetabularia (Bracket, 1967) constituted an important 
stimulus to consider the possibility that protein may be 
synthesized at sites which are very distant from cell nucleus. 
There is evidence that axon can survive for a considerable 
period of time after its transection from the cell body and 
can synthesize ribonucleic acid and protein particularly in 
chloroblasts. 
Protein synthesis in isolated synaptosomes have been shown 
by various workers as discussed earlier (cf. Introduction; 
Autilio and Appel, 1968; Austin and Morgan, 1967 and Goldberg, 
1971). The lack of visible ribosomes in both the axon and its 
endings does not I"lle out the possibility of protein synthesis 
in such tissues, since RNA with base ratios consistent with 
ribosomal RNA has been found in Mauthner axons of fish 
r 
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(Edstrom et al., 1962) and in cranial nerve roots in cat 
(Koenig, 1965). RNA is present in synaptosomes in particular 
in the non-mitochondrial membrane deprived from these synaptic 
organelles (Austin and Morgan, 1967). Studying protein syn-
thesis in vitro synaptosomal preparation, Austin and Morgan 
(1967) showed that uptake of radioactive amino acid was 
linear for an hour. The synaptosomal fraction was broken down 
to its components by osmotic shock. Membranes, soluble pro-
tein and mitochondria derived from osmotically shocked synap-
tosomes were all labelled with amino acid showing the most 
rapid rate of labelling. Their results stongly suggested that 
synaptosomes can synthesize protein and since not only mito-
chondria but also synaptosomal membranes and soluble protein 
were labelled, it seemed possible that a protein synthetic 
machinery exists either in the membrane or the cytoplasm of 
nerve ending. Various workers used protein synthesis inhibi-
tors to differentiate the biosynthesis of proteins in the 
synaptosomes and in particular to determine whether the syn-
thesis is of synaptosomal or mitochondrial type. It could be 
argued that the amino acid incorporation is not into synapto-
some at all, but is merely the result of an uptake by some 
contaminants such as bacteria, mitochondria or ribosomes. 
Autilio et al.(1968) showed that bacteria isolated from the 
incubation mixture incorporated leucine linearly for at least 
127 
5 hours, whereas the rate of incorporation into synaptosomal 
protein fell off rapidly after 20-30 minutes. These bacteria 
were very sensitive to chloramphenicol inhibition, whereas the 
synaptosomes are not. Mitochondria from brain synthesize pro-
tein (Campbell et al., 1966, Bachelard, 1966) but despite the 
inclusion of mitochondria within the nerve ending, all of the 
protein synthesis cannot be due to mitochondria. The sensi-
tivity of mitochondrial protein synthesis to chloramphenicol 
. . 
has been demonstrated for mitochondria from a wide range of 
tissue including brain (Kroon, 1963, Clark-Walker and Linnane, 
1967) and yet synaptosomal protein synthesis was inhibited by 
only 25%, a figure which suggests contribution made to the 
system by both synaptosomal and contaminating mitochondria 
(Austin and Morgan, 1967). Mitochondria derived from synapto-
some showed less than 2% of the incorporated isotope in a sol-
ubie fraction isolated after sonication (Autilio et al., 1968). 
The soluble protein isolated from synaptosome after incubation 
with leucine had about 20% of the total incorporated label. 
Contamination by free ribosomes released from other struc-
tures is not a problem in this system. Brain ribosomal system 
is inhibited almost completely by incubation with ribonuclease, 
but the intact synaptosomal system is unaffected (Campbell et al., 
1966). When labelled microsomes added to a brain homogenate 
did not contaminate the synaptosomal fraction which was 
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subsequently isolated from the homogenate (Austin and Morgan, 
The origin of axonal RNA is unknown. It could be trans-
ported from the cell body or from Schwann cells or glia along 
the axon. It does seem however that the nerve receives the 
RNA or RNA precursor in some way by transport along the nerve 
rather by direct uptake fro111 the blood. 
Our study was undertaken to study the mechanism by which 
AChE is formed at the external membrane of the pre- and post-
synaptic terminal and the junctional complex. The question 
was whether it is formed locally or was transported from the 
cell body. AChE is associated chiefly with membranous struc-
tures in rat brain (Toschi, 1959). At the synaptic area, it 
has been shown to be localized on the external membrane of the 
presynaptic terminal and in the junctional complex. The hypo-
thesis on the functional significance of AChE is based in part 
on their known localization. The membrane-bound enzyme has 
implications for function which are different than those for the 
function at the cytoplasmic-localized enzyme and the hypothesis 
of the functional AChE and the related hypothesis of Koelle 
{1961) are based on the identification of functional AChE at 
the synaptic membranes. 
! 
I 
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We studied the synthesis of AChE in the 20-day old rat 
following DFP injections (3.5 mg/kg). For a period of 15 days 
nerve endings synthesized or replaced 47% of the inhibited AChE, 
while rnicrosomes replaced 42% of the inhibited enzyme. Since 
this period represents a period of rapid growth in the animal, 
attempts were made to differentiate the enzyme arising due to 
normal growth and those arising due to enzyme replacement af'ter 
DFP inhibition. After the appropriate corrections, it was f'ound 
that AChE synthesized to replac~ the DFP inhibited enzyme a.mounted 
to 43% a~ the nerve endings and to 16% at the rnicrosomes. 
The ability of' synaptosomes to incorporate (c14) leucine 
into their proteins was found to decrease with the age of the rat 
{Austin and Morgan, 1967). However our data indicate the pre-
.sence of a AChE synthesizing :machinery at the nerve endings of 
· older (58 days older) as well as of younger animals (20 days 
old). In 58 day old rats following DFP injections (2.0 mg/kg), 
ther nerve endings synthesized and replaced 64% of the inhibited 
AChE, while microsomes replaced 45% of the inhibited enzyme. 
According to some investigators {Weiss and Hiscoe, 1948) 
proteins are presu.~ed to be transported to nerve endings from 
the cell body following its synthesis at rnicroson . .;s. If nerve 
ending AChE had its origin in the cell body and was transported 
from the rnicrosomes at the cell body, a faster rate of micro-
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somal AChE synthesis compared to its appearance at nerve 
endings could be expected following DFP administration. 
There would be a time lag, if replacement is dependent on 
microsomal synthesis for the enzyme and its subsequent trans-
port from microsomes to nerve endings. Altogether it would 
take time for AChE to be transported from the cell body to 
the nerve endings. Since AChE is a protein of high molecular 
weight, it would probably be transported by a slow process. 
we.never found a time lag in nerve endings either in 20 day 
or 58 day old rats, in fact recovery data indicate an earlier 
onset of AChE synthesis. This evidence indicates that the 
synthesis of AChE may occur in the nerve endings. The 
higher rate of synthesis of AChE in nerve endings as com-
pared to the microsome of older animal following DFP might 
be due to higher initial inhibition of AChE which occured in 
these animals. Our 'results throw a light on the paradox of 
coexistence of free cytoplasmic acetyl choline and acetyl-
cholinesterase in the same cell which is conconnnitant with 
the concept of the axoplasmic transport. As the nerve ending 
fraction synthesized their ovm AChE at the membrane, there will 
not be a need to supply the enzyme from the cell body and there 
would be no cytoplasmic enzyme capable of AChE hydrolysis. 
PROPERTIES OF THE MEMBRANE BOUND AChE: 
Several enzymes have been extracted from the membranes 
and their properties were found to be different from those of 
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the naturally-bound enzymes. This phenomenon has been termed 
allotopy (Racker, 1967). The first example of allotopy to be 
described was that of mitochondrial ATPase (Fl) (Racker, 1967). 
In its membrane-bound form, the enzyme was sensitive to oligo-
mycin and I~.I\f. dicyclohexyl carbodiimide; in the soluble form 
this sensitivity was lost but the enzyme became cold labile. 
Solubilizing the succinic dehydrogenase from the irmer membrane 
of mitochondria, various workers found modifications of proper-
ties of the enzyme. The catalytic properties of the membrane-
bound enzyme was found to be different from the soluble dehy-
drogenase (Cerletti et al., 1967). The iron chelating agent 
TTA (2 Thionyl Trifluoreacetone, 4,4,4,4 Trifluoro-1-(2-thionyl) 
1-3 butane dione) was found to inhibit only the membrane..:bound 
enzyme at low concentrations (Redfearn, 1965). The membrane-
bound dehydrogenase was found to be more stable than the solu-
bilized one (King, 1963). Other enzymes have also been shown 
to exhibit this phenomenon of allotopy. 
THE PROPERTIES OF THE MEMBRANE-BOUND ENZYME are different due 
to the difference in their surroundings. The properties may 
be influenced by 1) the general chemical and physical nature 
of the membrane, 2) by specific interactions of the enzyme 
with various molecules in its immediate neighborhood and 
3) by local effect of the enzyme and that of its neighbors. 
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We decided to solubilize the membrane-bound enzyme and 
study the difference in property between the soluble enzyme 
and the membrane-bound enzyme. Initially as a model system, 
we studied the effect of Triton X-100 on the human brain AChE. 
We found considerable activation of the enzyme with 13 
Triton X-100 (Table 6). Other workers also found activation 
of AChE with Triton X-100.. Harwood and Hawthorne (1969) found 
considerable stimulation of ACbE with.Triton X-100 (cf. also 
Crone, 1971). Fiszer and De Robertis (1967) claimed only 
solubilization of the enzyme with Triton X-100 though their 
Triton X-100 treated mitochondrial fraction showed an increase 
in activity. 
In the case of the human brain, we found an increase in 
AChE activity in the supernatant with Triton X-100, without 
concomitant change in the activity of the sediment. The analy-
tical data indicate that the increase in acetylcholinesterase 
activity that is demonstrable with the use of Triton X-100 
in the extractive media is not due to more complete extrac-
tion of the enzyme from the particulate to which it is bound 
but to changes in the properties of the catalytic protein. 
This is evidenced by change in supernatant acti\~ty without 
any connnensurate changes in the activity of the residue. These 
changes could be due to the catalytic protein released from 
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association with membrane fragments; as originally associated 
with the membrane, AChE may have been not fully active. The 
nature of the binding of enzyme to membrane could be altered. 
This can lead to either the unmasking of hidden catalytic 
sites by release of an allosteric inhibitory mechanism or by 
conformational changes in the molecule due to rupture of lipo-
philic bonds. It appears that Triton X-100 alters the conforma-
tion of the enziroe resulting in an enhancement of catalytic 
activity. 
The effect of Triton X-100 on the AChE activity of sub-
cellular fractions of DFP (3.5 mg/kg)-treated 20-day old rats 
was also studied. The Triton X-100 treated microsomal and 
synaptosomal fraction displayed a lower percent of AChE inhibi-
tion following DFP as compared to buffer treated fractions. 
The difference in inhibition between the Triton X-100 treated 
enzyme and the soluble enzyme was around 10-12% in the case of 
microsomes and nerve endings. This fraction might represent a 
pool of reserve enzyme or the membrane-bound enzyme which is 
not accessible to DFP. It is also possible that Triton X-100 
treatment opens active sites which are not normally available 
for interaction with substrates or it might represent the 
newly synthesized enzymes _which are not available to substrates 
normally. 
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Effect of Triton X-100 on nerve ending microsomal AChE 
of control and DFP-treated rats at various intervals of time 
in 20 day old rats (age 20-35 days). In the case of microsomes 
(Fig. 11), the specific activity of the enzyme released by 
Triton X-100 decreased with the age of the animal, while the 
specific activity of the soluble enzyme increased with age. 
In the DFP-treated group, the soluble enzyme increased, .while 
the enzyme released by Triton X-100 remained almost constant 
during aging. This situation was markedly different in the 
nerve ending fraction (Figure 12) as in this case the soluble 
as well as Triton-released enzyme increased both in control as 
well as DFP treated animals. The large increase in Triton-
released enzyme found in nerve endings at various ages may 
represent a reserve or a pool enzyme. In microsomes only the 
soluble enzyme increased at various ages whereas the Triton 
released enzyme decreased during the various time intervals. 
The main physiological function of AChE is at the nerve 
endings. It is possible to have a pool of enzyme acting as 
a reservoir at nerve endings. The increase in Triton releas-
able enzyme at nerve ending following DFP was not accompanied 
by a similar increase or decrease at the microsomal enzyme level. 
This further indicates that the nerve endings possess an inde-
pendent protein synthesizing machinery of nerve endings. The 
ability of the nerve endings to synthesize the soluble as well 
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as the membrane-bound enzyme is clearly shown. 
We excluded by appropriate tests the possibility that 
our results were related to microsomal contamination of the 
synaptosomes (cf. Table X). If the nerve endings were con-
taminated with microsomes, the enzyme recovery would follow 
a pattern similar to microsomes. The absence of such pattern 
diminishes the possibility of the results arising from rr.icro-
somal contamination. As the p~rcent·of enzyme activity was 
calculated against the values from control rats, the minimal 
error which may arise from microsomal contamination is elimin-
ated to a large extent. 
ISOENZYMES OF ACETYLCHOLINESTERASE 
We have resolved several bands with AChE activity in 
rat brain tissue by polyacryla.mide gel electrophoresis. Since 
the soluble extract gave a similar pattern in the case of the 
microsomes and of the nerve endings, we used a 1% Triton X-100 
extract which showed differences in isoenzyme pattern of nerve 
ending and microsomes. As 1% Triton produced consistent re-
sults, it was used in this experiment. Five hours after DFP 
injection (3.5 mg/kg), microsomal isoenzymes extracted by 1% 
Triton X-100 showed differential inhibition patterns (Fig. 13). 
A~er analyzing the results by a densitometer, the order of 
inhibition of the 4 microsomal isoenzymes on the day of injec-
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tion was 82, 49, 25 and o<1/o for isoenzymes 4, 2, 3 and 1 re-
spectively. The rate at which these isoenzymes were replaced 
by newly synthesized enzyme was also different (Table 8). 
The nerve ending isoenzymes underwent a different order 
of inhibition and recovery as compared to microsomal isoenzymes. 
On the day of injection, order of inhibition of the isoenzymes 
of nerve endings was as follows: Isoenzyme 4 (83%), Isoenzyme 
1 (72%), Isoenzyme 3 (30%), Isoenzyme 2 (4%). In a period of 
15 days, the inhibition of isoenzyme 4 was reduced to 16% and 
isoenzyme 1 to 25%. The other two isoenzymes were completely 
replaced by newly synthesized enzyme. Again, the recovery of 
nerve ending isoenzyme were different from that of microsomal 
isoenzymes. If the two subcellular fractions, namely micro-
somes and nerve endings exhibited similar pattern of inhibi-
tion and recovery, then the question of contamination of micro-
somes in nerve ending arises. Furthermore, comparing the 
differences between the inhibition and recovery of microsomal 
and nerve ending isoenzyme confirms the notion of independent 
synthesis of AChE in the nerve endings. On the day of injection,· 
the inhibition on microsomal isoenzyme 1 was zero, but the nerve 
ending isoenzyme 1 was inhibited 82%. Isoenzyme 2 was on the 
way to recovery in microsomes, whereas at nerve endings it was 
completely replaced by newly synthesized enzyme for the same 
period. Isoenzyme 4 which seems to be a dominant one in both 
f 
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subcellular fractions, was synthesized to 67% at the nerve 
endings and to 45% at the microsomes following inhibition 
with DFP. These data again indicate the independent protein 
synthesizing machinery at the nerve ending. 
Microsomal and nerve ending isoenzyme pattern were 
reproduced following various freezing and thawing procedures. 
This indicates that they are separate units and are not formed 
by recombination of subunits. If the nerve ending isoenzymes 
were supplied by the microsomes by axoplasmic transport, then 
the order of inhibition with DFP and resynthesis would follow 
the same pattern. The two sets of isoenzymes (microsomal and 
nerve ending) follow entirely a different course following 
their inhibition with DFP. These results further support 
the presence of an independent protein synthesizing machinery 
at the nerve endings which is also responsible for the synthesis 
of isoenzymes. Davies and Agranoff (1968) in three different 
kinds of experiments have demonstrated' that there is an isoen-
zyme of rat retina with an unusual half life of about 3 hours. 
Studies with several enzymes have indicated that these proteins 
are synthesized with a zero order reaction rate and degraded 
randomly with a first order rate (Rechagl and Weston, 1967). 
In our preparations, isoenzyme 4 from nerve ending had a 
half life of 11 days while the microsomal isoenzyme 4 had a 
half life of 16 days. Rest of the isoenzymes at the micro-
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somes and nerve ending exhibited half lives ranging from 11 to 
50 days. The significance of this difference in the turnover 
rate of these isoenzymes is uncertain. The isoenzyme with a 
fast turnover rate may act as a precursor to other isoenzymes. 
These isoenzymes may have a different physiological role. In 
the case of nerve endings, the rapidly recovering isoenzyme 
might represent the functional enzyme responsible for the 
transmitter hydrolysis. The other three isoenzymes might 
have different roles. They may act as a precursor to the 
other enzymes. In microsomes, a different set of conditions 
may exist. 
Wenthold et al., (1974) also confirmed the existence 
of multiple active forms of rat brain acetylcholinesterase and 
ob~erved six forms by electrofocusing the enzyme. The six 
forms separated by electrofocusing were similar in several 
respects. They found ~hem to be glyco-protein containing a 
subunit of same molecular weight with a distinct, reproduc-
ible isoelectric point. Specific isoenzymes were found to be 
concentrated in different subcellular locations. Similar to 
our results, they also noted the existence of enzyme in soluble 
and membrane-bound forms and the differences in the enzymes 
from these two different origin were also seen. On treating 
the isoenzymes with neuraminidase, they did not find any altera-
tion in the isoelectric pattern. 
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Studying AChE isoenzymes in mouse brain, Kahayashi et al., 
1973, found three different isoenzymes differing in PH optima, 
Km and inhibitory properties. The three isoenzymes were found 
to be distributed in different subcellular fractions. They 
proposed different physiological f\lnction for these isoenzymes. 
The heterogenity of the rat brain synaptosomal AChE has been 
shown electrophoretically by Glebov et al., (1970). Using a 
different extraction medium, they found differences in number 
of AChE bands in synaptosomes and in mitochondria (Glebov et al., 
1971). The physiological function of the isoenzymes remains to 
be determined, but it seems likely that they correlated to the 
different subcellular localization of the enzyme. In the case 
of the choline acetyltransferase, Fonnum and Malthe Sorenssen 
(1973) sought to correlate a higher isoelectric point and 
·higher positive charge with enhanced tendency to bond to 
negatively charged residues in membranes. So far the charge 
distribution among the different forms of AChE does not corre-
late in any obvious way with electrostatic binding properties 
of the membranes. Probably when more is known about structure 
of neuronal membranes, light will be thrown regarding the 
localization of these AChE isoenzymes to the membrane surface. 
The isoenzymic forms though catalyzing the same reaction do 
generally have distinct catalytic properties which presumably 
enables each of them to function in accord with physiological 
requirements either at different sites within the cell or in 
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distinct metabolic sequences {Stadtman, 1968). The most 
important biological question posed by isoenzyme is simply 
their existence. They must clearly confer great advantages 
to an organism, else they would not be so common. But just 
what each isoenzyme does that distinguishes it from others 
is still largely unknown. 
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CONCLUSIONS AND SUMMARY 
The protein requirement of synapses poses a unique 
problem as they are located at some distance from the cell body. 
The macromolecular requirement of synapses is a problem by 
itself in normal state as well as in pathological conditions. 
The question arises as to whether synapses synthesize all 
their proteins or do they depend on the cell body for proteins. 
As a model to study such a mechanism, we chose a system of 
isolated synaptosomes and microsomes from 20 and 58 day rat 
brain previously injected with DFP and studied specifically 
the synthesis of AChE. In 20-day old rats, following DFP, 
47% of the inhibited AChE was synthesized at nerve endings, 
while for the same period 42% of the inhibited enzyme was 
synthesized at microsomes. Since 'the period represents a 
period of rapid growth in the animal, attempts were made to 
differentiate the enzyme arising due to normal growth and those 
arising due to enzyme replacement after DFP inhibition. After 
the appropriate corrections, it was found that AChE synthesized 
to replace the DFP inhibited enzyme amounted to 43% at the 
nerve endings and to 16% at the microsomes. In 58 day old 
rats, 64% of the inhibited nerve ending AChE was synthesized 
and for the same period microsomes synthesized 45% of the 
inhibited enzyme. This phenomenon was not an age dependent 
one as it was found in both age groups. AChE was found to 
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be synthesized at nerve endings without a concomittant increase 
or decrease of microsomal enzyme which suggested an independent 
synthesizing machinery of nerve endings. When Triton X-100 
was used to solubilize AChE, the inhibition due to DFP ~ras 
considerably less in nerve terminals and microsomes compared 
to DFP inhibition measured in buffer treated fractions. These 
results suggest that a reservoir of the enzyme is not available 
tc substrate and to inhibitors such as DFP. 
We also found differences in the rate of inhibition and 
recovery of isoenzymes in the microsomal and nerve ending 
fraction following DFP which f'urther confirmed the independent 
synthesizing machinery of the nerve endings. On the day of 
injection, the order of inhibition of the 4 microsomal iso-
enzymes was 81, 49, 25 and oo/o for isoenzymes 4, 3, 2, 1. 
Fifteen days following DFP, the inhibition of isoenzyme· 4 
was 3&/o and isoenzyme 2 was 25%. In the same period, inhibited 
isoenzyme 3 was completely replaced by newly synthesized AChE. 
The inhibition and recovery of nerve ending isoenzyme were 
also studied in a manner similar to those of the microsomal 
isoenzymes. On the day of injection, the isoenzymes 4, 3, 2 
and 1 were inhibiter. 83, 30, 4 and 82% respectively. Fifteen 
days following DFP injection, the inhibition of isoenzyme 4 
and 1 was 16 and 25 percent respectively. Inhibited isoenzyme 
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3 and 2 were completely replaced by newly synthesized enzyme. 
The isoenzymes of nerve ending demonstrated different order of 
sensitivity to DFP and of the recovery rate indicating a 
different turnover rate. 
Certain hypothesis were made regarding the f'unction of 
these isoenzymes. Microsomes might supply the enzyme around 
the cell body which prevents the proliferation of Ach into 
cell from other sources. Nerve endings might supply the 
enzyme at the junctional complex whose main role is to 
.hydrolyze the transmitter following chemical transmission. 
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